# Danaher Corporation timeline entity: /record/danaher.md id: ent_danaher Danaher Corporation's timeline holds 575 claims from 2006 to 2026: 2 people, 564 money & deals, 9 other. 9 are undated. The latest took effect on October 15, 2026. Kinds: People 2 (/timelines/danaher.md?kind=people) · Money & deals 564 (/timelines/danaher.md?kind=money) · Products 0 (/timelines/danaher.md?kind=products) · Models 0 (/timelines/danaher.md?kind=models) · Other 9 (/timelines/danaher.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2006 - 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 317,810,000 United States dollar | superseded | [clm_91403501BB4D](/claim/clm_91403501BB4D.md) ## 2007 - 2007-12-31 to 2008-06-27 | money | cash_and_equivalents | 239,108,000 United States dollar | superseded | [clm_27FEAFBAD9D2](/claim/clm_27FEAFBAD9D2.md) - 2007-12-31 to 2008-12-31 | money | net_income | 1,369,904,000 United States dollar | superseded | [clm_ED8098932465](/claim/clm_ED8098932465.md) - 2007-12-31 to 2008-12-31 | money | operating_income | 1,740,709,000 United States dollar | superseded | [clm_8DA9F7570776](/claim/clm_8DA9F7570776.md) - 2007-12-31 to 2008-12-31 | money | research_and_development | 601,424,000 United States dollar | superseded | [clm_3C8F84285364](/claim/clm_3C8F84285364.md) - 2007-12-31 to 2008-12-31 | money | revenue | 11,025,917,000 United States dollar | superseded | [clm_431EFB564490](/claim/clm_431EFB564490.md) ## 2008 - 2008-06-27 to 2008-09-26 | money | cash_and_equivalents | 284,100,000 United States dollar | superseded | [clm_F5CD6D29D1C1](/claim/clm_F5CD6D29D1C1.md) - 2008-06-27 to 2008-09-26 | money | quarterly_net_income | 363,448,000 United States dollar | superseded | [clm_BBB183296CCE](/claim/clm_BBB183296CCE.md) - 2008-06-27 to 2008-09-26 | money | quarterly_operating_income | 510,464,000 United States dollar | superseded | [clm_00F9ADD61C57](/claim/clm_00F9ADD61C57.md) - 2008-06-27 to 2008-09-26 | money | quarterly_research_and_development | 189,866,000 United States dollar | superseded | [clm_6C1741D43720](/claim/clm_6C1741D43720.md) - 2008-06-27 to 2008-09-26 | money | quarterly_revenue | 3,283,895,000 United States dollar | superseded | [clm_79D3BB7FB0CD](/claim/clm_79D3BB7FB0CD.md) - 2008-09-26 to 2008-12-31 | money | cash_and_equivalents | 286,519,000 United States dollar | superseded | [clm_9FCB92F5A689](/claim/clm_9FCB92F5A689.md) - 2008-09-26 to 2009-04-03 | money | quarterly_net_income | 371,992,000 United States dollar | superseded | [clm_5541970D6859](/claim/clm_5541970D6859.md) - 2008-09-26 to 2009-04-03 | money | quarterly_operating_income | 522,140,000 United States dollar | superseded | [clm_C48DC830C11C](/claim/clm_C48DC830C11C.md) - 2008-09-26 to 2009-04-03 | money | quarterly_research_and_development | 182,006,000 United States dollar | superseded | [clm_2D3667F18AF2](/claim/clm_2D3667F18AF2.md) - 2008-09-26 to 2009-04-03 | money | quarterly_revenue | 3,208,181,000 United States dollar | superseded | [clm_3CC1C145CA1E](/claim/clm_3CC1C145CA1E.md) - 2008-12-31 to 2009-04-03 | money | cash_and_equivalents | 392,854,000 United States dollar | superseded | [clm_DAAB87363316](/claim/clm_DAAB87363316.md) - 2008-12-31 to 2009-12-31 | money | net_income | 1,317,631,000 United States dollar | superseded | [clm_20997A520702](/claim/clm_20997A520702.md) - 2008-12-31 to 2009-12-31 | money | operating_income | 1,869,477,000 United States dollar | superseded | [clm_1C91AC5DA319](/claim/clm_1C91AC5DA319.md) - 2008-12-31 to 2009-12-31 | money | research_and_development | 725,443,000 United States dollar | superseded | [clm_700181073709](/claim/clm_700181073709.md) - 2008-12-31 to 2009-12-31 | money | revenue | 12,697,456,000 United States dollar | superseded | [clm_151AF4C89FBF](/claim/clm_151AF4C89FBF.md) - 2008-12-31 to 2009-07-03 | money | total_assets | 17,490,128,000 United States dollar | superseded | [clm_ECBA6F766EF0](/claim/clm_ECBA6F766EF0.md) - 2008-12-31 to 2009-07-03 | money | total_equity | 9,808,562,000 United States dollar | superseded | [clm_4A4A6E380ABE](/claim/clm_4A4A6E380ABE.md) ## 2009 - 2009-04-03 to 2009-07-03 | money | cash_and_equivalents | 975,945,000 United States dollar | superseded | [clm_34AB5B356D89](/claim/clm_34AB5B356D89.md) - 2009-04-03 to 2009-07-03 | money | quarterly_net_income | 237,712,000 United States dollar | superseded | [clm_759D1EAB97D8](/claim/clm_759D1EAB97D8.md) - 2009-04-03 to 2009-07-03 | money | quarterly_operating_income | 340,219,000 United States dollar | superseded | [clm_1AC6D4573C10](/claim/clm_1AC6D4573C10.md) - 2009-04-03 to 2009-07-03 | money | quarterly_research_and_development | 160,895,000 United States dollar | superseded | [clm_DDE3BBE47372](/claim/clm_DDE3BBE47372.md) - 2009-04-03 to 2009-07-03 | money | quarterly_revenue | 2,627,744,000 United States dollar | superseded | [clm_74562D8AC6B6](/claim/clm_74562D8AC6B6.md) - 2009-07-03 to 2009-10-02 | money | cash_and_equivalents | 1,258,411,000 United States dollar | superseded | [clm_9EF513A17CBE](/claim/clm_9EF513A17CBE.md) - 2009-07-03 to 2009-10-02 | money | quarterly_net_income | 295,694,000 United States dollar | superseded | [clm_CB50833A178C](/claim/clm_CB50833A178C.md) - 2009-07-03 to 2009-10-02 | money | quarterly_operating_income | 343,946,000 United States dollar | superseded | [clm_F6503349D522](/claim/clm_F6503349D522.md) - 2009-07-03 to 2009-10-02 | money | quarterly_research_and_development | 158,500,000 United States dollar | superseded | [clm_901EA678C6C0](/claim/clm_901EA678C6C0.md) - 2009-07-03 to 2009-10-02 | money | quarterly_revenue | 2,673,609,000 United States dollar | superseded | [clm_00C92AA2B06D](/claim/clm_00C92AA2B06D.md) - 2009-07-03 to 2009-10-16 | money | shares_outstanding | 319,738,236 shares | superseded | [clm_4725FC60B073](/claim/clm_4725FC60B073.md) - 2009-07-03 to 2009-10-02 | money | total_assets | 18,322,397,000 United States dollar | superseded | [clm_F39C7A71765E](/claim/clm_F39C7A71765E.md) - 2009-07-03 to 2009-10-02 | money | total_equity | 10,602,527,000 United States dollar | superseded | [clm_FCA2EEB4421C](/claim/clm_FCA2EEB4421C.md) - 2009-10-02 to 2009-12-31 | money | cash_and_equivalents | 1,636,231,000 United States dollar | superseded | [clm_9EB597F9F716](/claim/clm_9EB597F9F716.md) - 2009-10-02 to 2010-04-02 | money | quarterly_net_income | 351,363,000 United States dollar | superseded | [clm_BF3A215F4DBD](/claim/clm_BF3A215F4DBD.md) - 2009-10-02 to 2010-04-02 | money | quarterly_operating_income | 464,597,000 United States dollar | superseded | [clm_9E84B26E2EB0](/claim/clm_9E84B26E2EB0.md) - 2009-10-02 to 2010-04-02 | money | quarterly_research_and_development | 159,040,000 United States dollar | superseded | [clm_E5AD9C63D1B4](/claim/clm_E5AD9C63D1B4.md) - 2009-10-02 to 2010-04-02 | money | quarterly_revenue | 2,750,693,000 United States dollar | superseded | [clm_CA4859A81408](/claim/clm_CA4859A81408.md) - 2009-10-02 to 2009-12-31 | money | total_assets | 19,161,907,000 United States dollar | superseded | [clm_0DA4DB82CDE1](/claim/clm_0DA4DB82CDE1.md) - 2009-10-02 to 2009-12-31 | money | total_equity | 11,210,529,000 United States dollar | superseded | [clm_ABF3A87B9392](/claim/clm_ABF3A87B9392.md) - 2009-10-16 to 2010-02-11 | money | shares_outstanding | 321,234,857 shares | superseded | [clm_6CF54831533C](/claim/clm_6CF54831533C.md) - 2009-12-31 to 2010-04-02 | money | cash_and_equivalents | 1,721,920,000 United States dollar | superseded | [clm_040C45D7CA70](/claim/clm_040C45D7CA70.md) - 2009-12-31 to 2010-12-31 | money | net_income | 1,151,704,000 United States dollar | superseded | [clm_D6C2212DD8E2](/claim/clm_D6C2212DD8E2.md) - 2009-12-31 to 2010-12-31 | money | operating_income | 1,542,476,000 United States dollar | superseded | [clm_272ACF3197D2](/claim/clm_272ACF3197D2.md) - 2009-12-31 to 2010-12-31 | money | research_and_development | 632,651,000 United States dollar | superseded | [clm_3B7BBD6D7A95](/claim/clm_3B7BBD6D7A95.md) - 2009-12-31 to 2010-12-31 | money | revenue | 11,184,938,000 United States dollar | superseded | [clm_57516E5E8648](/claim/clm_57516E5E8648.md) - 2009-12-31 to 2010-04-02 | money | total_assets | 19,595,420,000 United States dollar | superseded | [clm_C5574C67CFA6](/claim/clm_C5574C67CFA6.md) - 2009-12-31 to 2010-04-02 | money | total_equity | 11,630,176,000 United States dollar | superseded | [clm_299CD6B2247D](/claim/clm_299CD6B2247D.md) ## 2010 - 2010-02-11 to 2010-02-12 | money | shares_outstanding | 659,181,326 shares | superseded | [clm_5C21D38226DF](/claim/clm_5C21D38226DF.md) - 2010-02-12 to 2010-04-02 | money | shares_outstanding | 323,482,284 shares | superseded | [clm_065A7CA85F6C](/claim/clm_065A7CA85F6C.md) - 2010-04-02 to 2010-07-02 | money | cash_and_equivalents | 806,368,000 United States dollar | superseded | [clm_A2800C3B82DA](/claim/clm_A2800C3B82DA.md) - 2010-04-02 to 2010-07-02 | money | quarterly_net_income | 300,233,000 United States dollar | superseded | [clm_3019E112D90C](/claim/clm_3019E112D90C.md) - 2010-04-02 to 2010-07-02 | money | quarterly_operating_income | 433,366,000 United States dollar | superseded | [clm_0D2ECA82CDBF](/claim/clm_0D2ECA82CDBF.md) - 2010-04-02 to 2010-07-02 | money | quarterly_research_and_development | 187,232,000 United States dollar | superseded | [clm_AEE63C646A61](/claim/clm_AEE63C646A61.md) - 2010-04-02 to 2010-07-02 | money | quarterly_revenue | 3,092,220,000 United States dollar | superseded | [clm_B5DE891656D5](/claim/clm_B5DE891656D5.md) - 2010-04-02 to 2010-07-16 | money | shares_outstanding | 324,646,610 shares | superseded | [clm_E035DBF93F82](/claim/clm_E035DBF93F82.md) - 2010-04-02 to 2010-07-02 | money | total_assets | 19,880,646,000 United States dollar | superseded | [clm_2987E8D6FDDD](/claim/clm_2987E8D6FDDD.md) - 2010-04-02 to 2010-07-02 | money | total_equity | 11,853,178,000 United States dollar | superseded | [clm_480EB89E26DE](/claim/clm_480EB89E26DE.md) - 2010-07-02 to 2010-10-01 | money | cash_and_equivalents | 1,232,936,000 United States dollar | superseded | [clm_12F4AF8CD73E](/claim/clm_12F4AF8CD73E.md) - 2010-07-02 to 2010-10-01 | money | quarterly_net_income | 372,476,000 United States dollar | superseded | [clm_2E79C544390A](/claim/clm_2E79C544390A.md) - 2010-07-02 to 2010-10-01 | money | quarterly_operating_income | 533,850,000 United States dollar | superseded | [clm_A50EC57B73BE](/claim/clm_A50EC57B73BE.md) - 2010-07-02 to 2010-10-01 | money | quarterly_research_and_development | 197,650,000 United States dollar | superseded | [clm_7E3A61E6F719](/claim/clm_7E3A61E6F719.md) - 2010-07-02 to 2010-10-01 | money | quarterly_revenue | 3,310,921,000 United States dollar | superseded | [clm_1185F81BA48B](/claim/clm_1185F81BA48B.md) - 2010-07-02 to 2010-10-01 | money | total_assets | 20,078,957,000 United States dollar | superseded | [clm_BABB2C4938DB](/claim/clm_BABB2C4938DB.md) - 2010-07-02 to 2010-10-01 | money | total_equity | 12,058,010,000 United States dollar | superseded | [clm_FA353084AC10](/claim/clm_FA353084AC10.md) - 2010-07-16 to 2010-10-15 | money | shares_outstanding | 652,622,896 shares | superseded | [clm_F9159B62B9E1](/claim/clm_F9159B62B9E1.md) - 2010-10-01 to 2010-12-31 | money | cash_and_equivalents | 1,635,041,000 United States dollar | superseded | [clm_826031E1D252](/claim/clm_826031E1D252.md) - 2010-10-01 to 2011-04-01 | money | quarterly_net_income | 646,435,000 United States dollar | superseded | [clm_CB1F50A14303](/claim/clm_CB1F50A14303.md) - 2010-10-01 to 2011-04-01 | money | quarterly_operating_income | 572,650,000 United States dollar | superseded | [clm_74541955233C](/claim/clm_74541955233C.md) - 2010-10-01 to 2011-04-01 | money | quarterly_research_and_development | 202,591,000 United States dollar | superseded | [clm_D41545663B9C](/claim/clm_D41545663B9C.md) - 2010-10-01 to 2011-04-01 | money | quarterly_revenue | 3,190,193,000 United States dollar | superseded | [clm_DC48D4BF1637](/claim/clm_DC48D4BF1637.md) - 2010-10-01 to 2010-12-31 | money | total_assets | 21,497,835,000 United States dollar | superseded | [clm_30EA96F03911](/claim/clm_30EA96F03911.md) - 2010-10-01 to 2010-12-31 | money | total_equity | 13,171,933,000 United States dollar | superseded | [clm_481F2464F9FB](/claim/clm_481F2464F9FB.md) - 2010-10-15 to 2011-04-15 | money | shares_outstanding | 653,954,253 shares | superseded | [clm_3D3FE7644DB1](/claim/clm_3D3FE7644DB1.md) - 2010-12-31 to 2011-04-01 | money | cash_and_equivalents | 1,632,980,000 United States dollar | superseded | [clm_5192699B900A](/claim/clm_5192699B900A.md) - 2010-12-31 to 2011-12-31 | money | net_income | 1,793,000,000 United States dollar | superseded | [clm_9317F04FD609](/claim/clm_9317F04FD609.md) - 2010-12-31 to 2011-12-31 | money | operating_income | 2,166,374,000 United States dollar | superseded | [clm_A3DA9AA4FE02](/claim/clm_A3DA9AA4FE02.md) - 2010-12-31 to 2011-12-31 | money | research_and_development | 809,481,000 United States dollar | superseded | [clm_55B9D0C1F427](/claim/clm_55B9D0C1F427.md) - 2010-12-31 to 2011-12-31 | money | revenue | 13,202,602,000 United States dollar | superseded | [clm_A07079607BA4](/claim/clm_A07079607BA4.md) - 2010-12-31 to 2011-04-01 | money | total_assets | 22,217,130,000 United States dollar | superseded | [clm_F7FD4DB7EF58](/claim/clm_F7FD4DB7EF58.md) - 2010-12-31 to 2011-04-01 | money | total_equity | 13,711,010,000 United States dollar | superseded | [clm_7A06F6B8BA7A](/claim/clm_7A06F6B8BA7A.md) ## 2011 - 2011-04-01 to 2011-07-01 | money | cash_and_equivalents | 1,593,559,000 United States dollar | superseded | [clm_25F668C31729](/claim/clm_25F668C31729.md) - 2011-04-01 to 2011-07-01 | money | quarterly_net_income | 429,358,000 United States dollar | superseded | [clm_E5D9D50C6E82](/claim/clm_E5D9D50C6E82.md) - 2011-04-01 to 2011-07-01 | money | quarterly_operating_income | 590,588,000 United States dollar | superseded | [clm_3307A884B517](/claim/clm_3307A884B517.md) - 2011-04-01 to 2011-07-01 | money | quarterly_research_and_development | 217,573,000 United States dollar | superseded | [clm_6D00CD61253C](/claim/clm_6D00CD61253C.md) - 2011-04-01 to 2011-07-01 | money | quarterly_revenue | 3,345,702,000 United States dollar | superseded | [clm_1DFC738C518E](/claim/clm_1DFC738C518E.md) - 2011-04-01 to 2011-07-01 | money | total_assets | 23,034,881,000 United States dollar | superseded | [clm_849D3F5227E2](/claim/clm_849D3F5227E2.md) - 2011-04-01 to 2011-07-01 | money | total_equity | 14,659,179,000 United States dollar | superseded | [clm_20A6621B3EE6](/claim/clm_20A6621B3EE6.md) - 2011-04-15 to 2011-07-15 | money | shares_outstanding | 664,056,433 shares | superseded | [clm_91823F9D2BDF](/claim/clm_91823F9D2BDF.md) - 2011-07-01 to 2011-09-30 | money | cash_and_equivalents | 551,583,000 United States dollar | superseded | [clm_386185D56424](/claim/clm_386185D56424.md) - 2011-07-01 to 2011-09-30 | money | quarterly_net_income | 648,764,000 United States dollar | superseded | [clm_F2EFDF669639](/claim/clm_F2EFDF669639.md) - 2011-07-01 to 2011-09-30 | money | quarterly_operating_income | 626,103,000 United States dollar | superseded | [clm_2A2C6E01B2DE](/claim/clm_2A2C6E01B2DE.md) - 2011-07-01 to 2011-09-30 | money | quarterly_research_and_development | 235,803,000 United States dollar | superseded | [clm_EB2308EADEF1](/claim/clm_EB2308EADEF1.md) - 2011-07-01 to 2011-09-30 | money | quarterly_revenue | 3,711,674,000 United States dollar | superseded | [clm_3A774BE16631](/claim/clm_3A774BE16631.md) - 2011-07-01 to 2011-09-30 | money | total_assets | 31,513,376,000 United States dollar | superseded | [clm_92A3CA8AAA80](/claim/clm_92A3CA8AAA80.md) - 2011-07-01 to 2011-09-30 | money | total_equity | 16,489,496,000 United States dollar | superseded | [clm_457D14C4700E](/claim/clm_457D14C4700E.md) - 2011-07-15 to 2011-10-14 | money | shares_outstanding | 685,554,656 shares | superseded | [clm_671ED1FA14B8](/claim/clm_671ED1FA14B8.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 484,368,000 United States dollar | superseded | [clm_1FAC41557282](/claim/clm_1FAC41557282.md) - 2011-09-30 to 2012-03-30 | money | quarterly_net_income | 523,428,000 United States dollar | superseded | [clm_F0DB4089A3C9](/claim/clm_F0DB4089A3C9.md) - 2011-09-30 to 2012-03-30 | money | quarterly_operating_income | 656,144,000 United States dollar | superseded | [clm_A266797D50AE](/claim/clm_A266797D50AE.md) - 2011-09-30 to 2012-03-30 | money | quarterly_research_and_development | 289,602,000 United States dollar | superseded | [clm_C31C8F016F2F](/claim/clm_C31C8F016F2F.md) - 2011-09-30 to 2012-03-30 | money | quarterly_revenue | 4,518,089,000 United States dollar | superseded | [clm_0D3FC01AF5FF](/claim/clm_0D3FC01AF5FF.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 30,618,424,000 United States dollar | superseded | [clm_E67D9281B635](/claim/clm_E67D9281B635.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 16,496,791,000 United States dollar | superseded | [clm_47AA50F754F8](/claim/clm_47AA50F754F8.md) - 2011-10-14 to 2012-02-13 | money | shares_outstanding | 686,347,315 shares | superseded | [clm_E55B3CD37D02](/claim/clm_E55B3CD37D02.md) - 2011-12-31 to 2012-03-30 | money | cash_and_equivalents | 537,001,000 United States dollar | superseded | [clm_137BC072FC69](/claim/clm_137BC072FC69.md) - 2011-12-31 to 2012-12-31 | money | net_income | 2,172,264,000 United States dollar | superseded | [clm_2A428DF153C2](/claim/clm_2A428DF153C2.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 2,617,226,000 United States dollar | superseded | [clm_552A7CDB3908](/claim/clm_552A7CDB3908.md) - 2011-12-31 to 2012-12-31 | money | research_and_development | 1,018,526,000 United States dollar | superseded | [clm_ADE3883DB81A](/claim/clm_ADE3883DB81A.md) - 2011-12-31 to 2012-12-31 | money | revenue | 16,090,540,000 United States dollar | superseded | [clm_BE354676E05B](/claim/clm_BE354676E05B.md) - 2011-12-31 to 2012-03-30 | money | total_assets | 29,949,447,000 United States dollar | superseded | [clm_3B23F696456C](/claim/clm_3B23F696456C.md) - 2011-12-31 to 2012-03-30 | money | total_equity | 16,904,783,000 United States dollar | superseded | [clm_2DCFFC5F47F9](/claim/clm_2DCFFC5F47F9.md) ## 2012 - 2012-02-13 to 2012-04-13 | money | shares_outstanding | 689,294,694 shares | superseded | [clm_76FE61232D1C](/claim/clm_76FE61232D1C.md) - 2012-03-30 to 2012-06-29 | money | cash_and_equivalents | 1,043,283,000 United States dollar | superseded | [clm_359795B3F2DA](/claim/clm_359795B3F2DA.md) - 2012-03-30 to 2012-06-29 | money | quarterly_net_income | 612,912,000 United States dollar | superseded | [clm_DCE273328E61](/claim/clm_DCE273328E61.md) - 2012-03-30 to 2012-06-29 | money | quarterly_operating_income | 734,868,000 United States dollar | superseded | [clm_CBB0BBE0E0CA](/claim/clm_CBB0BBE0E0CA.md) - 2012-03-30 to 2012-06-29 | money | quarterly_research_and_development | 270,124,000 United States dollar | superseded | [clm_59BB8AC2CE56](/claim/clm_59BB8AC2CE56.md) - 2012-03-30 to 2012-06-29 | money | quarterly_revenue | 4,316,220,000 United States dollar | superseded | [clm_C95E1959DBB7](/claim/clm_C95E1959DBB7.md) - 2012-03-30 to 2012-06-29 | money | total_assets | 30,420,959,000 United States dollar | superseded | [clm_6FFD72193B4E](/claim/clm_6FFD72193B4E.md) - 2012-03-30 to 2012-06-29 | money | total_equity | 17,823,305,000 United States dollar | superseded | [clm_36F8A9DC251E](/claim/clm_36F8A9DC251E.md) - 2012-04-13 to 2012-07-13 | money | shares_outstanding | 692,753,675 shares | superseded | [clm_28AE4D381ADA](/claim/clm_28AE4D381ADA.md) - 2012-06-29 to 2012-09-28 | money | cash_and_equivalents | 1,118,240,000 United States dollar | superseded | [clm_08C6C5F5575A](/claim/clm_08C6C5F5575A.md) - 2012-06-29 to 2012-09-28 | money | quarterly_net_income | 600,149,000 United States dollar | superseded | [clm_57173D70FA65](/claim/clm_57173D70FA65.md) - 2012-06-29 to 2012-09-28 | money | quarterly_operating_income | 811,274,000 United States dollar | superseded | [clm_D5BDA7F03428](/claim/clm_D5BDA7F03428.md) - 2012-06-29 to 2012-09-28 | money | quarterly_research_and_development | 283,602,000 United States dollar | superseded | [clm_AD0DDEFD18F4](/claim/clm_AD0DDEFD18F4.md) - 2012-06-29 to 2012-09-28 | money | quarterly_revenue | 4,553,459,000 United States dollar | superseded | [clm_1EB42A93520E](/claim/clm_1EB42A93520E.md) - 2012-06-29 to 2012-09-28 | money | total_assets | 31,170,583,000 United States dollar | superseded | [clm_5444C80B3312](/claim/clm_5444C80B3312.md) - 2012-06-29 to 2012-09-28 | money | total_equity | 18,301,916,000 United States dollar | superseded | [clm_3387B97710AE](/claim/clm_3387B97710AE.md) - 2012-07-13 to 2012-10-12 | money | shares_outstanding | 695,355,477 shares | superseded | [clm_0A95A749EF59](/claim/clm_0A95A749EF59.md) - 2012-09-28 to 2012-12-31 | money | cash_and_equivalents | 1,541,335,000 United States dollar | superseded | [clm_74A66F8296C0](/claim/clm_74A66F8296C0.md) - 2012-09-28 to 2013-03-29 | money | quarterly_net_income | 548,735,000 United States dollar | superseded | [clm_930C25B6C39C](/claim/clm_930C25B6C39C.md) - 2012-09-28 to 2013-03-29 | money | quarterly_operating_income | 755,809,000 United States dollar | superseded | [clm_B1CD07DFE47C](/claim/clm_B1CD07DFE47C.md) - 2012-09-28 to 2013-03-29 | money | quarterly_research_and_development | 289,517,000 United States dollar | superseded | [clm_8AA1F66D937D](/claim/clm_8AA1F66D937D.md) - 2012-09-28 to 2013-03-29 | money | quarterly_revenue | 4,415,543,000 United States dollar | superseded | [clm_650504EF7FD8](/claim/clm_650504EF7FD8.md) - 2012-09-28 to 2012-12-31 | money | total_assets | 31,585,420,000 United States dollar | superseded | [clm_B0185D81D1AF](/claim/clm_B0185D81D1AF.md) - 2012-09-28 to 2012-12-31 | money | total_equity | 18,886,086,000 United States dollar | superseded | [clm_1C4804F46D1A](/claim/clm_1C4804F46D1A.md) - 2012-10-12 to 2013-02-11 | money | shares_outstanding | 692,687,947 shares | superseded | [clm_DB66F91063CB](/claim/clm_DB66F91063CB.md) - 2012-12-31 to 2013-03-29 | money | cash_and_equivalents | 1,678,700,000 United States dollar | superseded | [clm_183DD7E89432](/claim/clm_183DD7E89432.md) - 2012-12-31 to 2013-12-31 | money | net_income | 2,392,200,000 United States dollar | superseded | [clm_5D11137AEE03](/claim/clm_5D11137AEE03.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 3,165,100,000 United States dollar | superseded | [clm_E18ACAA34B06](/claim/clm_E18ACAA34B06.md) - 2012-12-31 to 2013-12-31 | money | research_and_development | 1,137,900,000 United States dollar | superseded | [clm_EE41ECEADAF5](/claim/clm_EE41ECEADAF5.md) - 2012-12-31 to 2013-12-31 | money | revenue | 18,260,400,000 United States dollar | superseded | [clm_F85E73F9E966](/claim/clm_F85E73F9E966.md) - 2012-12-31 to 2013-03-29 | money | total_assets | 32,941,000,000 United States dollar | superseded | [clm_31D117C310A5](/claim/clm_31D117C310A5.md) - 2012-12-31 to 2013-03-29 | money | total_equity | 19,016,500,000 United States dollar | superseded | [clm_EAB44DE73542](/claim/clm_EAB44DE73542.md) ## 2013 - 2013-02-11 to 2013-04-12 | money | shares_outstanding | 690,246,149 shares | superseded | [clm_1648D3A9A397](/claim/clm_1648D3A9A397.md) - 2013-03-29 to 2013-06-28 | money | cash_and_equivalents | 2,150,700,000 United States dollar | superseded | [clm_B9F19FFBE28B](/claim/clm_B9F19FFBE28B.md) - 2013-03-29 to 2013-06-28 | money | quarterly_net_income | 691,900,000 United States dollar | superseded | [clm_97D5465595AE](/claim/clm_97D5465595AE.md) - 2013-03-29 to 2013-06-28 | money | quarterly_operating_income | 730,900,000 United States dollar | superseded | [clm_33277C676150](/claim/clm_33277C676150.md) - 2013-03-29 to 2013-06-28 | money | quarterly_research_and_development | 296,400,000 United States dollar | superseded | [clm_AC53E6775F57](/claim/clm_AC53E6775F57.md) - 2013-03-29 to 2013-06-28 | money | quarterly_revenue | 4,444,700,000 United States dollar | superseded | [clm_FD9D0F855886](/claim/clm_FD9D0F855886.md) - 2013-03-29 to 2013-06-28 | money | total_assets | 32,469,300,000 United States dollar | superseded | [clm_1FDE01D4C3D9](/claim/clm_1FDE01D4C3D9.md) - 2013-03-29 to 2013-06-28 | money | total_equity | 19,681,100,000 United States dollar | superseded | [clm_8B79869959CB](/claim/clm_8B79869959CB.md) - 2013-04-12 to 2013-07-12 | money | shares_outstanding | 692,707,073 shares | superseded | [clm_8C77EBB7CE8A](/claim/clm_8C77EBB7CE8A.md) - 2013-06-28 to 2013-09-27 | money | cash_and_equivalents | 2,324,900,000 United States dollar | superseded | [clm_B668562D9327](/claim/clm_B668562D9327.md) - 2013-06-28 to 2013-09-27 | money | quarterly_net_income | 616,800,000 United States dollar | superseded | [clm_C69D113EF317](/claim/clm_C69D113EF317.md) - 2013-06-28 to 2013-09-27 | money | quarterly_operating_income | 843,600,000 United States dollar | superseded | [clm_53528A3B4B90](/claim/clm_53528A3B4B90.md) - 2013-06-28 to 2013-09-27 | money | quarterly_research_and_development | 312,200,000 United States dollar | superseded | [clm_2A8CFCEBF030](/claim/clm_2A8CFCEBF030.md) - 2013-06-28 to 2013-09-27 | money | quarterly_revenue | 4,737,500,000 United States dollar | superseded | [clm_7ABF3B5617BD](/claim/clm_7ABF3B5617BD.md) - 2013-06-28 to 2013-09-27 | money | total_assets | 33,109,000,000 United States dollar | superseded | [clm_87B30A68899D](/claim/clm_87B30A68899D.md) - 2013-06-28 to 2013-09-27 | money | total_equity | 20,296,100,000 United States dollar | superseded | [clm_E013B7C16C67](/claim/clm_E013B7C16C67.md) - 2013-07-12 to 2013-10-11 | money | shares_outstanding | 695,568,931 shares | superseded | [clm_9989284DB0EA](/claim/clm_9989284DB0EA.md) - 2013-09-27 to 2013-12-31 | money | cash_and_equivalents | 1,995,600,000 United States dollar | superseded | [clm_D70B653A4C1D](/claim/clm_D70B653A4C1D.md) - 2013-09-27 to 2014-03-28 | money | quarterly_net_income | 597,000,000 United States dollar | superseded | [clm_3B91B4E7185E](/claim/clm_3B91B4E7185E.md) - 2013-09-27 to 2014-03-28 | money | quarterly_operating_income | 812,400,000 United States dollar | superseded | [clm_98FDA2E9267C](/claim/clm_98FDA2E9267C.md) - 2013-09-27 to 2014-03-28 | money | quarterly_research_and_development | 309,100,000 United States dollar | superseded | [clm_ACAFD76CE744](/claim/clm_ACAFD76CE744.md) - 2013-09-27 to 2014-03-28 | money | quarterly_revenue | 4,669,100,000 United States dollar | superseded | [clm_2A126BBEE2DD](/claim/clm_2A126BBEE2DD.md) - 2013-09-27 to 2013-12-31 | money | total_assets | 33,721,200,000 United States dollar | superseded | [clm_D9FB96E98788](/claim/clm_D9FB96E98788.md) - 2013-09-27 to 2013-12-31 | money | total_equity | 21,304,600,000 United States dollar | superseded | [clm_972CF7AD6347](/claim/clm_972CF7AD6347.md) - 2013-10-11 to 2014-02-10 | money | shares_outstanding | 697,199,830 shares | superseded | [clm_BF63F624C63E](/claim/clm_BF63F624C63E.md) - 2013-12-31 to 2014-03-28 | money | cash_and_equivalents | 3,115,200,000 United States dollar | superseded | [clm_EA3231B0B1BB](/claim/clm_EA3231B0B1BB.md) - 2013-12-31 to 2014-12-31 | money | net_income | 2,695,000,000 United States dollar | superseded | [clm_F4ECB099B13D](/claim/clm_F4ECB099B13D.md) - 2013-12-31 to 2014-12-31 | money | operating_income | 3,274,900,000 United States dollar | superseded | [clm_9BB18120534B](/claim/clm_9BB18120534B.md) - 2013-12-31 to 2014-12-31 | money | research_and_development | 1,249,900,000 United States dollar | superseded | [clm_D2F5428DCD4D](/claim/clm_D2F5428DCD4D.md) - 2013-12-31 to 2014-12-31 | money | revenue | 19,118,000,000 United States dollar | superseded | [clm_4250AD5C8128](/claim/clm_4250AD5C8128.md) - 2013-12-31 to 2014-03-28 | money | total_assets | 34,672,200,000 United States dollar | superseded | [clm_778D95FFE604](/claim/clm_778D95FFE604.md) - 2013-12-31 to 2014-03-28 | money | total_equity | 22,385,300,000 United States dollar | superseded | [clm_20C08DE902EC](/claim/clm_20C08DE902EC.md) ## 2014 - 2014-02-10 to 2014-04-11 | money | shares_outstanding | 698,482,191 shares | superseded | [clm_FC4C0F328E14](/claim/clm_FC4C0F328E14.md) - 2014-03-28 to 2014-06-27 | money | cash_and_equivalents | 3,346,500,000 United States dollar | superseded | [clm_4BFD236FD7C0](/claim/clm_4BFD236FD7C0.md) - 2014-03-28 to 2014-06-27 | money | quarterly_net_income | 579,700,000 United States dollar | superseded | [clm_CDA44C423F01](/claim/clm_CDA44C423F01.md) - 2014-03-28 to 2014-06-27 | money | quarterly_operating_income | 788,900,000 United States dollar | superseded | [clm_62E133128D55](/claim/clm_62E133128D55.md) - 2014-03-28 to 2014-06-27 | money | quarterly_research_and_development | 313,400,000 United States dollar | superseded | [clm_7128B126E5A1](/claim/clm_7128B126E5A1.md) - 2014-03-28 to 2014-06-27 | money | quarterly_revenue | 4,662,700,000 United States dollar | superseded | [clm_8653742F08ED](/claim/clm_8653742F08ED.md) - 2014-03-28 to 2014-06-27 | money | total_assets | 35,042,600,000 United States dollar | superseded | [clm_26F604A4E58A](/claim/clm_26F604A4E58A.md) - 2014-03-28 to 2014-06-27 | money | total_equity | 22,961,700,000 United States dollar | superseded | [clm_B712FF257A52](/claim/clm_B712FF257A52.md) - 2014-04-11 to 2014-07-11 | money | shares_outstanding | 699,532,283 shares | superseded | [clm_98F5D6C73544](/claim/clm_98F5D6C73544.md) - 2014-06-27 to 2014-09-26 | money | cash_and_equivalents | 3,321,100,000 United States dollar | superseded | [clm_17DFC030EA85](/claim/clm_17DFC030EA85.md) - 2014-06-27 to 2014-09-26 | money | quarterly_net_income | 676,400,000 United States dollar | superseded | [clm_D099F5C5A6C4](/claim/clm_D099F5C5A6C4.md) - 2014-06-27 to 2014-09-26 | money | quarterly_operating_income | 889,300,000 United States dollar | superseded | [clm_C934A347148E](/claim/clm_C934A347148E.md) - 2014-06-27 to 2014-09-26 | money | quarterly_research_and_development | 336,400,000 United States dollar | superseded | [clm_0AB3D4246DF0](/claim/clm_0AB3D4246DF0.md) - 2014-06-27 to 2014-09-26 | money | quarterly_revenue | 4,963,600,000 United States dollar | superseded | [clm_C6E4138F9ACA](/claim/clm_C6E4138F9ACA.md) - 2014-06-27 to 2014-09-26 | money | total_assets | 35,652,100,000 United States dollar | superseded | [clm_1C9F58477402](/claim/clm_1C9F58477402.md) - 2014-06-27 to 2014-09-26 | money | total_equity | 23,720,500,000 United States dollar | superseded | [clm_B2D1FD4F9CF7](/claim/clm_B2D1FD4F9CF7.md) - 2014-07-11 to 2014-10-10 | money | shares_outstanding | 700,684,075 shares | superseded | [clm_D7388D3E31C3](/claim/clm_D7388D3E31C3.md) - 2014-09-26 to 2014-12-31 | money | cash_and_equivalents | 4,025,300,000 United States dollar | superseded | [clm_D727BC40B0AD](/claim/clm_D727BC40B0AD.md) - 2014-09-26 to 2015-04-03 | money | quarterly_net_income | 680,600,000 United States dollar | superseded | [clm_3D30EE3AE935](/claim/clm_3D30EE3AE935.md) - 2014-09-26 to 2015-04-03 | money | quarterly_operating_income | 865,800,000 United States dollar | superseded | [clm_07A5C4A26606](/claim/clm_07A5C4A26606.md) - 2014-09-26 to 2015-04-03 | money | quarterly_research_and_development | 328,300,000 United States dollar | superseded | [clm_4A3AF2E7793C](/claim/clm_4A3AF2E7793C.md) - 2014-09-26 to 2015-04-03 | money | quarterly_revenue | 4,870,300,000 United States dollar | superseded | [clm_D46796717666](/claim/clm_D46796717666.md) - 2014-09-26 to 2014-12-31 | money | total_assets | 35,535,900,000 United States dollar | superseded | [clm_1B90B1C43C44](/claim/clm_1B90B1C43C44.md) - 2014-09-26 to 2014-12-31 | money | total_equity | 23,740,700,000 United States dollar | superseded | [clm_6AA85760CF4E](/claim/clm_6AA85760CF4E.md) - 2014-10-10 to 2015-02-09 | money | shares_outstanding | 702,691,595 shares | superseded | [clm_5B1C3EEA10FD](/claim/clm_5B1C3EEA10FD.md) - 2014-12-31 to 2015-04-03 | money | cash_and_equivalents | 3,005,600,000 United States dollar | superseded | [clm_15D7AAD231D1](/claim/clm_15D7AAD231D1.md) - 2014-12-31 to 2015-12-31 | money | net_income | 2,598,400,000 United States dollar | superseded | [clm_B80439FA3BA6](/claim/clm_B80439FA3BA6.md) - 2014-12-31 to 2015-12-31 | money | operating_income | 3,431,300,000 United States dollar | superseded | [clm_9BCB797B6449](/claim/clm_9BCB797B6449.md) - 2014-12-31 to 2015-12-31 | money | research_and_development | 1,314,200,000 United States dollar | superseded | [clm_CAE7021E597B](/claim/clm_CAE7021E597B.md) - 2014-12-31 to 2015-12-31 | money | revenue | 19,913,800,000 United States dollar | superseded | [clm_DB8543BB8E40](/claim/clm_DB8543BB8E40.md) - 2014-12-31 to 2015-04-03 | money | total_assets | 36,991,700,000 United States dollar | superseded | [clm_C237EBF37257](/claim/clm_C237EBF37257.md) - 2014-12-31 to 2015-04-03 | money | total_equity | 23,378,100,000 United States dollar | superseded | [clm_42D72864C041](/claim/clm_42D72864C041.md) ## 2015 - 2015-02-09 to 2015-04-17 | money | shares_outstanding | 705,777,722 shares | superseded | [clm_161151814F94](/claim/clm_161151814F94.md) - 2015-04-03 to 2015-07-03 | money | cash_and_equivalents | 2,511,000,000 United States dollar | superseded | [clm_5BBAC74868C5](/claim/clm_5BBAC74868C5.md) - 2015-04-03 to 2015-07-03 | money | quarterly_net_income | 569,800,000 United States dollar | superseded | [clm_B79895C24A05](/claim/clm_B79895C24A05.md) - 2015-04-03 to 2015-07-03 | money | quarterly_operating_income | 774,200,000 United States dollar | superseded | [clm_0D7C7542CE2F](/claim/clm_0D7C7542CE2F.md) - 2015-04-03 to 2015-07-03 | money | quarterly_research_and_development | 339,100,000 United States dollar | superseded | [clm_285A85864202](/claim/clm_285A85864202.md) - 2015-04-03 to 2015-07-03 | money | quarterly_revenue | 4,873,300,000 United States dollar | superseded | [clm_8EC38C6F3DBB](/claim/clm_8EC38C6F3DBB.md) - 2015-04-03 to 2015-07-03 | money | total_assets | 36,072,300,000 United States dollar | superseded | [clm_625F83470768](/claim/clm_625F83470768.md) - 2015-04-03 to 2015-07-03 | money | total_equity | 23,321,000,000 United States dollar | superseded | [clm_830BA7BE885B](/claim/clm_830BA7BE885B.md) - 2015-04-17 to 2015-07-20 | money | shares_outstanding | 707,525,745 shares | superseded | [clm_16E94FE412A0](/claim/clm_16E94FE412A0.md) - 2015-07-03 to 2015-10-02 | money | cash_and_equivalents | 3,342,000,000 United States dollar | superseded | [clm_762D4CF43F4E](/claim/clm_762D4CF43F4E.md) - 2015-07-03 to 2015-10-02 | money | quarterly_net_income | 695,600,000 United States dollar | superseded | [clm_9383FA95F9E1](/claim/clm_9383FA95F9E1.md) - 2015-07-03 to 2015-10-02 | money | quarterly_operating_income | 931,100,000 United States dollar | superseded | [clm_6248FB8C2985](/claim/clm_6248FB8C2985.md) - 2015-07-03 to 2015-10-02 | money | quarterly_research_and_development | 344,900,000 United States dollar | superseded | [clm_5F325DA870A8](/claim/clm_5F325DA870A8.md) - 2015-07-03 to 2015-10-02 | money | quarterly_revenue | 5,127,100,000 United States dollar | superseded | [clm_016C124B2AA0](/claim/clm_016C124B2AA0.md) - 2015-07-03 to 2015-10-02 | money | total_assets | 36,986,800,000 United States dollar | superseded | [clm_DA1B5BF7CBD8](/claim/clm_DA1B5BF7CBD8.md) - 2015-07-03 to 2015-10-02 | money | total_equity | 24,101,200,000 United States dollar | superseded | [clm_552D92A4B419](/claim/clm_552D92A4B419.md) - 2015-07-20 to 2015-10-16 | money | shares_outstanding | 683,488,074 shares | superseded | [clm_C9100679A5C2](/claim/clm_C9100679A5C2.md) - 2015-10-02 to 2015-12-31 | money | cash_and_equivalents | 1,833,500,000 United States dollar | superseded | [clm_16A1DDD146A7](/claim/clm_16A1DDD146A7.md) - 2015-10-02 to 2016-04-01 | money | quarterly_net_income | 1,403,300,000 United States dollar | superseded | [clm_A85288653DE5](/claim/clm_A85288653DE5.md) - 2015-10-02 to 2016-04-01 | money | quarterly_operating_income | 800,800,000 United States dollar | superseded | [clm_4B92F64619FB](/claim/clm_4B92F64619FB.md) - 2015-10-02 to 2016-04-01 | money | quarterly_research_and_development | 307,900,000 United States dollar | superseded | [clm_810B5EB9EC59](/claim/clm_810B5EB9EC59.md) - 2015-10-02 to 2016-04-01 | money | quarterly_revenue | 5,023,400,000 United States dollar | superseded | [clm_611D0D48A177](/claim/clm_611D0D48A177.md) - 2015-10-02 to 2015-12-31 | money | total_assets | 49,707,900,000 United States dollar | superseded | [clm_175149596D3C](/claim/clm_175149596D3C.md) - 2015-10-02 to 2015-12-31 | money | total_equity | 23,112,700,000 United States dollar | superseded | [clm_3A08DC380014](/claim/clm_3A08DC380014.md) - 2015-10-16 to 2016-02-09 | money | shares_outstanding | 685,285,314 shares | superseded | [clm_BF0F6B3002EE](/claim/clm_BF0F6B3002EE.md) - 2015-12-31 to 2016-04-01 | money | cash_and_equivalents | 790,800,000 United States dollar | superseded | [clm_8F8DEA80FBB9](/claim/clm_8F8DEA80FBB9.md) - 2015-12-31 to 2016-12-31 | money | net_income | 3,357,400,000 United States dollar | superseded | [clm_7AC51DB8B350](/claim/clm_7AC51DB8B350.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 3,469,100,000 United States dollar | superseded | [clm_7B237FC16FC9](/claim/clm_7B237FC16FC9.md) - 2015-12-31 to 2016-12-31 | money | research_and_development | 1,239,100,000 United States dollar | superseded | [clm_227EB19EB1DF](/claim/clm_227EB19EB1DF.md) - 2015-12-31 to 2016-12-31 | money | revenue | 20,563,100,000 United States dollar | superseded | [clm_96CAD070707F](/claim/clm_96CAD070707F.md) - 2015-12-31 to 2016-04-01 | money | total_assets | 48,222,200,000 United States dollar | superseded | [clm_120ED3DE21A7](/claim/clm_120ED3DE21A7.md) - 2015-12-31 to 2016-04-01 | money | total_equity | 23,690,300,000 United States dollar | superseded | [clm_4AC5A326E443](/claim/clm_4AC5A326E443.md) ## 2016 - 2016-02-09 to 2016-04-15 | money | shares_outstanding | 687,154,521 shares | superseded | [clm_46160D7886B5](/claim/clm_46160D7886B5.md) - 2016-04-01 to 2016-07-01 | money | cash_and_equivalents | 664,300,000 United States dollar | superseded | [clm_3AC137C9E3F6](/claim/clm_3AC137C9E3F6.md) - 2016-04-01 to 2016-07-01 | money | quarterly_net_income | 758,400,000 United States dollar | superseded | [clm_824ED3AFFCEE](/claim/clm_824ED3AFFCEE.md) - 2016-04-01 to 2016-07-01 | money | quarterly_operating_income | 882,100,000 United States dollar | superseded | [clm_29082A8F1079](/claim/clm_29082A8F1079.md) - 2016-04-01 to 2016-07-01 | money | quarterly_research_and_development | 319,800,000 United States dollar | superseded | [clm_E8BBF8BFAE7D](/claim/clm_E8BBF8BFAE7D.md) - 2016-04-01 to 2016-07-01 | money | quarterly_revenue | 5,387,200,000 United States dollar | superseded | [clm_006FFAC1B697](/claim/clm_006FFAC1B697.md) - 2016-04-01 to 2016-07-01 | money | total_assets | 48,385,600,000 United States dollar | superseded | [clm_34B639A21C3E](/claim/clm_34B639A21C3E.md) - 2016-04-01 to 2016-07-01 | money | total_equity | 24,504,700,000 United States dollar | superseded | [clm_7C8C0F0FF9EC](/claim/clm_7C8C0F0FF9EC.md) - 2016-04-15 to 2016-07-15 | money | shares_outstanding | 688,695,451 shares | superseded | [clm_91ECA95C5603](/claim/clm_91ECA95C5603.md) - 2016-07-01 to 2016-09-30 | money | cash_and_equivalents | 4,097,600,000 United States dollar | superseded | [clm_81FD187C7A67](/claim/clm_81FD187C7A67.md) - 2016-07-01 to 2016-09-30 | money | quarterly_net_income | 656,700,000 United States dollar | superseded | [clm_153423BCAB0E](/claim/clm_153423BCAB0E.md) - 2016-07-01 to 2016-09-30 | money | quarterly_operating_income | 1,034,500,000 United States dollar | superseded | [clm_9BA0F8D49709](/claim/clm_9BA0F8D49709.md) - 2016-07-01 to 2016-09-30 | money | quarterly_research_and_development | 336,600,000 United States dollar | superseded | [clm_2F83D07101F3](/claim/clm_2F83D07101F3.md) - 2016-07-01 to 2016-09-30 | money | quarterly_revenue | 5,785,000,000 United States dollar | superseded | [clm_CD9955691963](/claim/clm_CD9955691963.md) - 2016-07-01 to 2016-09-30 | money | total_assets | 51,503,700,000 United States dollar | superseded | [clm_690912D38D46](/claim/clm_690912D38D46.md) - 2016-07-01 to 2016-09-30 | money | total_equity | 25,045,100,000 United States dollar | superseded | [clm_9EA5BC3E5F7B](/claim/clm_9EA5BC3E5F7B.md) - 2016-07-15 to 2016-10-14 | money | shares_outstanding | 690,538,430 shares | superseded | [clm_C9E8805F384E](/claim/clm_C9E8805F384E.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 971,400,000 United States dollar | superseded | [clm_254E9F05F283](/claim/clm_254E9F05F283.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 391,600,000 United States dollar | superseded | [clm_05529DF70442](/claim/clm_05529DF70442.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 699,100,000 United States dollar | superseded | [clm_8CDAC045D4DE](/claim/clm_8CDAC045D4DE.md) - 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 241,100,000 United States dollar | superseded | [clm_775341B74E2B](/claim/clm_775341B74E2B.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 4,132,100,000 United States dollar | superseded | [clm_92BCCD1620EB](/claim/clm_92BCCD1620EB.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 41,297,500,000 United States dollar | superseded | [clm_87A970D387A6](/claim/clm_87A970D387A6.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 23,191,600,000 United States dollar | superseded | [clm_3A29F4CA42ED](/claim/clm_3A29F4CA42ED.md) - 2016-10-14 to 2017-02-09 | money | shares_outstanding | 691,702,118 shares | superseded | [clm_2BE4F8219E0A](/claim/clm_2BE4F8219E0A.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 963,700,000 United States dollar | superseded | [clm_9834F7C7079C](/claim/clm_9834F7C7079C.md) - 2016-12-31 to 2017-12-31 | money | net_income | 2,553,700,000 United States dollar | superseded | [clm_9658AE16B1C9](/claim/clm_9658AE16B1C9.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 2,750,900,000 United States dollar | superseded | [clm_771E5EC026DC](/claim/clm_771E5EC026DC.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 975,100,000 United States dollar | superseded | [clm_E8DE62294DDF](/claim/clm_E8DE62294DDF.md) - 2016-12-31 to 2017-12-31 | money | revenue | 16,882,400,000 United States dollar | superseded | [clm_8845066593D8](/claim/clm_8845066593D8.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 45,295,300,000 United States dollar | superseded | [clm_F85C378C699C](/claim/clm_F85C378C699C.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 23,002,800,000 United States dollar | superseded | [clm_F109EEF80EC0](/claim/clm_F109EEF80EC0.md) ## 2017 - 2017-02-09 to 2017-04-14 | money | shares_outstanding | 693,280,277 shares | superseded | [clm_9F201FFB2978](/claim/clm_9F201FFB2978.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 803,900,000 United States dollar | superseded | [clm_555D04002530](/claim/clm_555D04002530.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 506,100,000 United States dollar | superseded | [clm_A9C54A634683](/claim/clm_A9C54A634683.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 623,900,000 United States dollar | superseded | [clm_4C42BA3BCD6E](/claim/clm_4C42BA3BCD6E.md) - 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 267,400,000 United States dollar | superseded | [clm_B6490DED6F10](/claim/clm_B6490DED6F10.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 4,205,700,000 United States dollar | superseded | [clm_77C5D5CB5852](/claim/clm_77C5D5CB5852.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 45,245,100,000 United States dollar | superseded | [clm_D56BB1427AC7](/claim/clm_D56BB1427AC7.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 23,785,800,000 United States dollar | superseded | [clm_E6C9FA934E95](/claim/clm_E6C9FA934E95.md) - 2017-04-14 to 2017-07-14 | money | shares_outstanding | 694,120,308 shares | superseded | [clm_E2FD901533D6](/claim/clm_E2FD901533D6.md) - 2017-06-30 to 2017-09-29 | money | cash_and_equivalents | 726,400,000 United States dollar | superseded | [clm_873DEB846BF6](/claim/clm_873DEB846BF6.md) - 2017-06-30 to 2017-09-29 | money | quarterly_net_income | 557,300,000 United States dollar | superseded | [clm_991B2EDB414F](/claim/clm_991B2EDB414F.md) - 2017-06-30 to 2017-09-29 | money | quarterly_operating_income | 683,700,000 United States dollar | superseded | [clm_EEABF79C3824](/claim/clm_EEABF79C3824.md) - 2017-06-30 to 2017-09-29 | money | quarterly_research_and_development | 283,300,000 United States dollar | superseded | [clm_A42C4420623C](/claim/clm_A42C4420623C.md) - 2017-06-30 to 2017-09-29 | money | quarterly_revenue | 4,510,100,000 United States dollar | superseded | [clm_A498FC3F80BD](/claim/clm_A498FC3F80BD.md) - 2017-06-30 to 2017-09-29 | money | total_assets | 45,646,800,000 United States dollar | superseded | [clm_B5CF0D8A1A4E](/claim/clm_B5CF0D8A1A4E.md) - 2017-06-30 to 2017-09-29 | money | total_equity | 24,590,000,000 United States dollar | superseded | [clm_DD6266D08008](/claim/clm_DD6266D08008.md) - 2017-07-14 to 2017-10-13 | money | shares_outstanding | 694,689,883 shares | superseded | [clm_2D22A33078BA](/claim/clm_2D22A33078BA.md) - 2017-09-29 to 2017-12-31 | money | cash_and_equivalents | 648,600,000 United States dollar | superseded | [clm_69960C4E9451](/claim/clm_69960C4E9451.md) - 2017-09-29 to 2018-03-30 | money | quarterly_net_income | 572,100,000 United States dollar | superseded | [clm_3AC932CD6BD6](/claim/clm_3AC932CD6BD6.md) - 2017-09-29 to 2018-03-30 | money | quarterly_operating_income | 767,500,000 United States dollar | superseded | [clm_0522E5107170](/claim/clm_0522E5107170.md) - 2017-09-29 to 2018-03-30 | money | quarterly_research_and_development | 279,200,000 United States dollar | superseded | [clm_4C90CF2F08A0](/claim/clm_4C90CF2F08A0.md) - 2017-09-29 to 2018-03-30 | money | quarterly_revenue | 4,528,200,000 United States dollar | superseded | [clm_9FF36A2BE78E](/claim/clm_9FF36A2BE78E.md) - 2017-09-29 to 2017-12-31 | money | total_assets | 45,851,300,000 United States dollar | superseded | [clm_10FE63585E76](/claim/clm_10FE63585E76.md) - 2017-09-29 to 2017-12-31 | money | total_equity | 25,375,400,000 United States dollar | superseded | [clm_FE6A17CF6E75](/claim/clm_FE6A17CF6E75.md) - 2017-10-13 to 2018-02-08 | money | shares_outstanding | 695,605,257 shares | superseded | [clm_9BE292AA284A](/claim/clm_9BE292AA284A.md) - 2017-12-31 to 2018-03-30 | money | cash_and_equivalents | 630,300,000 United States dollar | superseded | [clm_40DE52C0F509](/claim/clm_40DE52C0F509.md) - 2017-12-31 to 2018-12-31 | money | net_income | 2,492,100,000 United States dollar | superseded | [clm_9B67117F57E8](/claim/clm_9B67117F57E8.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 3,021,200,000 United States dollar | superseded | [clm_71BE5BAE93CF](/claim/clm_71BE5BAE93CF.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 1,128,800,000 United States dollar | superseded | [clm_E4C975DE7608](/claim/clm_E4C975DE7608.md) - 2017-12-31 to 2018-12-31 | money | revenue | 18,329,700,000 United States dollar | superseded | [clm_1FB08EE24031](/claim/clm_1FB08EE24031.md) - 2017-12-31 to 2018-03-30 | money | total_assets | 46,648,600,000 United States dollar | superseded | [clm_352FEC19394E](/claim/clm_352FEC19394E.md) - 2017-12-31 to 2018-03-30 | money | total_equity | 26,358,200,000 United States dollar | superseded | [clm_9647F6F19879](/claim/clm_9647F6F19879.md) ## 2018 - 2018-02-08 to 2018-04-13 | money | shares_outstanding | 697,569,470 shares | superseded | [clm_10355A0302D9](/claim/clm_10355A0302D9.md) - 2018-03-30 to 2018-06-29 | money | cash_and_equivalents | 1,045,700,000 United States dollar | superseded | [clm_1D484FBB47D3](/claim/clm_1D484FBB47D3.md) - 2018-03-30 to 2018-06-29 | money | quarterly_net_income | 566,600,000 United States dollar | superseded | [clm_5A4A9193C6F7](/claim/clm_5A4A9193C6F7.md) - 2018-03-30 to 2018-06-29 | money | quarterly_operating_income | 743,000,000 United States dollar | superseded | [clm_991B1E53E999](/claim/clm_991B1E53E999.md) - 2018-03-30 to 2018-06-29 | money | quarterly_research_and_development | 298,700,000 United States dollar | superseded | [clm_878EC18D9F6F](/claim/clm_878EC18D9F6F.md) - 2018-03-30 to 2018-06-29 | money | quarterly_revenue | 4,695,400,000 United States dollar | superseded | [clm_AAC0A6666A8D](/claim/clm_AAC0A6666A8D.md) - 2018-03-30 to 2018-06-29 | money | total_assets | 47,145,200,000 United States dollar | superseded | [clm_E43261914BCE](/claim/clm_E43261914BCE.md) - 2018-03-30 to 2018-06-29 | money | total_equity | 27,189,900,000 United States dollar | superseded | [clm_48D0B9ECAE59](/claim/clm_48D0B9ECAE59.md) - 2018-04-13 to 2018-07-13 | money | shares_outstanding | 698,572,727 shares | superseded | [clm_4BE968052B9E](/claim/clm_4BE968052B9E.md) - 2018-06-29 to 2018-09-28 | money | cash_and_equivalents | 904,000,000 United States dollar | superseded | [clm_808768B550C0](/claim/clm_808768B550C0.md) - 2018-06-29 to 2018-09-28 | money | quarterly_net_income | 673,800,000 United States dollar | superseded | [clm_EE51A59CEBF7](/claim/clm_EE51A59CEBF7.md) - 2018-06-29 to 2018-09-28 | money | quarterly_operating_income | 867,500,000 United States dollar | superseded | [clm_D344DB440732](/claim/clm_D344DB440732.md) - 2018-06-29 to 2018-09-28 | money | quarterly_research_and_development | 311,700,000 United States dollar | superseded | [clm_51176BD47955](/claim/clm_51176BD47955.md) - 2018-06-29 to 2018-09-28 | money | quarterly_revenue | 4,981,000,000 United States dollar | superseded | [clm_0130B9F43A3D](/claim/clm_0130B9F43A3D.md) - 2018-06-29 to 2018-09-28 | money | total_assets | 48,055,800,000 United States dollar | superseded | [clm_0D274869F17B](/claim/clm_0D274869F17B.md) - 2018-06-29 to 2018-09-28 | money | total_equity | 27,212,300,000 United States dollar | superseded | [clm_094052ED727A](/claim/clm_094052ED727A.md) - 2018-07-13 to 2018-10-12 | money | shares_outstanding | 699,754,843 shares | superseded | [clm_A27F98BD5A86](/claim/clm_A27F98BD5A86.md) - 2018-09-28 to 2018-12-31 | money | cash_and_equivalents | 776,200,000 United States dollar | superseded | [clm_B30AEB3BAE58](/claim/clm_B30AEB3BAE58.md) - 2018-09-28 to 2019-03-29 | money | quarterly_net_income | 663,700,000 United States dollar | superseded | [clm_ECD14EB5E5FA](/claim/clm_ECD14EB5E5FA.md) - 2018-09-28 to 2019-03-29 | money | quarterly_operating_income | 830,700,000 United States dollar | superseded | [clm_3C26D72A4A40](/claim/clm_3C26D72A4A40.md) - 2018-09-28 to 2019-03-29 | money | quarterly_research_and_development | 301,200,000 United States dollar | superseded | [clm_0EDF77D03DD6](/claim/clm_0EDF77D03DD6.md) - 2018-09-28 to 2019-03-29 | money | quarterly_revenue | 4,853,100,000 United States dollar | superseded | [clm_E9A2F41A59E0](/claim/clm_E9A2F41A59E0.md) - 2018-09-28 to 2018-12-31 | money | total_assets | 47,719,500,000 United States dollar | superseded | [clm_E5E1256ED773](/claim/clm_E5E1256ED773.md) - 2018-09-28 to 2018-12-31 | money | total_equity | 27,673,400,000 United States dollar | superseded | [clm_6F5F37AD5538](/claim/clm_6F5F37AD5538.md) - 2018-10-12 to 2019-02-07 | money | shares_outstanding | 700,902,703 shares | superseded | [clm_15E6CBC06791](/claim/clm_15E6CBC06791.md) - 2018-12-31 to 2019-03-29 | money | cash_and_equivalents | 787,800,000 United States dollar | superseded | [clm_FDD9659988C7](/claim/clm_FDD9659988C7.md) - 2018-12-31 to 2019-12-31 | money | net_income | 2,650,900,000 United States dollar | superseded | [clm_9BB856541BDA](/claim/clm_9BB856541BDA.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 3,403,800,000 United States dollar | superseded | [clm_BAFEBE59E6D0](/claim/clm_BAFEBE59E6D0.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 1,231,200,000 United States dollar | superseded | [clm_CE4E6F908E65](/claim/clm_CE4E6F908E65.md) - 2018-12-31 to 2019-12-31 | money | revenue | 19,893,000,000 United States dollar | superseded | [clm_86ED16614C3F](/claim/clm_86ED16614C3F.md) - 2018-12-31 to 2019-03-29 | money | total_assets | 47,832,500,000 United States dollar | superseded | [clm_3DFE8330E0DF](/claim/clm_3DFE8330E0DF.md) - 2018-12-31 to 2019-03-29 | money | total_equity | 28,214,400,000 United States dollar | superseded | [clm_A69BC791268D](/claim/clm_A69BC791268D.md) ## 2019 - 2019-01-01 | people | cfo | Matthew R. McGrew | valid | [clm_31256A6E3F32](/claim/clm_31256A6E3F32.md) - 2019-02-07 to 2019-04-12 | money | shares_outstanding | 701,875,340 shares | superseded | [clm_3F7E806F8129](/claim/clm_3F7E806F8129.md) - 2019-03-29 to 2019-06-28 | money | cash_and_equivalents | 3,910,000,000 United States dollar | superseded | [clm_D2B36DF8AEF4](/claim/clm_D2B36DF8AEF4.md) - 2019-03-29 to 2019-06-28 | money | quarterly_net_income | 333,800,000 United States dollar | superseded | [clm_82DCDADDA130](/claim/clm_82DCDADDA130.md) - 2019-03-29 to 2019-06-28 | money | quarterly_operating_income | 723,800,000 United States dollar | superseded | [clm_D4F3C75EC134](/claim/clm_D4F3C75EC134.md) - 2019-03-29 to 2019-06-28 | money | quarterly_research_and_development | 310,800,000 United States dollar | superseded | [clm_070B554A5E6C](/claim/clm_070B554A5E6C.md) - 2019-03-29 to 2019-06-28 | money | quarterly_revenue | 4,879,900,000 United States dollar | superseded | [clm_31C53D29C5CD](/claim/clm_31C53D29C5CD.md) - 2019-03-29 to 2019-06-28 | money | total_assets | 51,774,400,000 United States dollar | superseded | [clm_99CC30415C45](/claim/clm_99CC30415C45.md) - 2019-03-29 to 2019-06-28 | money | total_equity | 31,556,600,000 United States dollar | superseded | [clm_ACE758027543](/claim/clm_ACE758027543.md) - 2019-04-12 to 2019-07-12 | money | shares_outstanding | 715,933,649 shares | superseded | [clm_1EBF30BDF09D](/claim/clm_1EBF30BDF09D.md) - 2019-06-28 to 2019-09-27 | money | cash_and_equivalents | 5,433,600,000 United States dollar | superseded | [clm_39BAADC888AD](/claim/clm_39BAADC888AD.md) - 2019-06-28 to 2019-09-27 | money | quarterly_net_income | 731,300,000 United States dollar | superseded | [clm_AABF99DFE2E5](/claim/clm_AABF99DFE2E5.md) - 2019-06-28 to 2019-09-27 | money | quarterly_operating_income | 883,800,000 United States dollar | superseded | [clm_22A30BC049D5](/claim/clm_22A30BC049D5.md) - 2019-06-28 to 2019-09-27 | money | quarterly_research_and_development | 321,800,000 United States dollar | superseded | [clm_CFE29F9A8C99](/claim/clm_CFE29F9A8C99.md) - 2019-06-28 to 2019-09-27 | money | quarterly_revenue | 5,156,600,000 United States dollar | superseded | [clm_64DF2DDCD35E](/claim/clm_64DF2DDCD35E.md) - 2019-06-28 to 2019-09-27 | money | total_assets | 53,322,000,000 United States dollar | superseded | [clm_EC92CDA7FC74](/claim/clm_EC92CDA7FC74.md) - 2019-06-28 to 2019-09-27 | money | total_equity | 32,201,200,000 United States dollar | superseded | [clm_A29155E252E2](/claim/clm_A29155E252E2.md) - 2019-07-12 to 2019-10-18 | money | shares_outstanding | 717,367,599 shares | superseded | [clm_F8349EFB3E92](/claim/clm_F8349EFB3E92.md) - 2019-09-27 to 2019-12-31 | money | cash_and_equivalents | 14,252,100,000 United States dollar | superseded | [clm_A574EFFBCA05](/claim/clm_A574EFFBCA05.md) - 2019-09-27 to 2020-04-03 | money | quarterly_net_income | 668,000,000 United States dollar | superseded | [clm_118DD5011573](/claim/clm_118DD5011573.md) - 2019-09-27 to 2020-04-03 | money | quarterly_operating_income | 834,800,000 United States dollar | superseded | [clm_3A4E3950632F](/claim/clm_3A4E3950632F.md) - 2019-09-27 to 2020-04-03 | money | quarterly_research_and_development | 318,900,000 United States dollar | superseded | [clm_3282525816E6](/claim/clm_3282525816E6.md) - 2019-09-27 to 2020-04-03 | money | quarterly_revenue | 5,037,300,000 United States dollar | superseded | [clm_5922AB5DB582](/claim/clm_5922AB5DB582.md) - 2019-09-27 to 2019-12-31 | money | total_assets | 61,531,100,000 United States dollar | superseded | [clm_FA693B4885A5](/claim/clm_FA693B4885A5.md) - 2019-09-27 to 2019-12-31 | money | total_equity | 32,502,300,000 United States dollar | superseded | [clm_736E0BDD8D1F](/claim/clm_736E0BDD8D1F.md) - 2019-10-18 to 2020-02-06 | money | shares_outstanding | 718,281,174 shares | superseded | [clm_93CF674AFAE5](/claim/clm_93CF674AFAE5.md) - 2019-12-31 to 2020-04-03 | money | cash_and_equivalents | 19,912,300,000 United States dollar | superseded | [clm_8EC9E8BD025F](/claim/clm_8EC9E8BD025F.md) - 2019-12-31 to 2020-12-31 | money | net_income | 3,008,200,000 United States dollar | superseded | [clm_B7297AAF3B76](/claim/clm_B7297AAF3B76.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 3,269,400,000 United States dollar | superseded | [clm_A9D6B0AC8747](/claim/clm_A9D6B0AC8747.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 1,126,000,000 United States dollar | superseded | [clm_1447F31C8BC0](/claim/clm_1447F31C8BC0.md) - 2019-12-31 to 2020-12-31 | money | revenue | 17,911,100,000 United States dollar | superseded | [clm_0FFD69832034](/claim/clm_0FFD69832034.md) - 2019-12-31 to 2020-04-03 | money | total_assets | 62,081,600,000 United States dollar | superseded | [clm_62D1201695A4](/claim/clm_62D1201695A4.md) - 2019-12-31 to 2020-04-03 | money | total_equity | 30,270,600,000 United States dollar | superseded | [clm_FF42023C3203](/claim/clm_FF42023C3203.md) ## 2020 - 2020-02-06 to 2020-05-01 | money | shares_outstanding | 696,237,113 shares | superseded | [clm_03D5B135F3C0](/claim/clm_03D5B135F3C0.md) - 2020-04-03 to 2020-07-03 | money | cash_and_equivalents | 4,367,700,000 United States dollar | superseded | [clm_E236026FF626](/claim/clm_E236026FF626.md) - 2020-04-03 to 2020-07-03 | money | quarterly_net_income | 595,100,000 United States dollar | superseded | [clm_F89A7D098BF6](/claim/clm_F89A7D098BF6.md) - 2020-04-03 to 2020-07-03 | money | quarterly_operating_income | 697,500,000 United States dollar | superseded | [clm_0B527475E29A](/claim/clm_0B527475E29A.md) - 2020-04-03 to 2020-07-03 | money | quarterly_research_and_development | 287,000,000 United States dollar | superseded | [clm_66DCC072441D](/claim/clm_66DCC072441D.md) - 2020-04-03 to 2020-07-03 | money | quarterly_revenue | 4,343,100,000 United States dollar | superseded | [clm_3B9488D997F5](/claim/clm_3B9488D997F5.md) - 2020-04-03 to 2020-07-03 | money | total_assets | 68,930,300,000 United States dollar | superseded | [clm_C7BA214997D4](/claim/clm_C7BA214997D4.md) - 2020-04-03 to 2020-07-03 | money | total_equity | 31,055,100,000 United States dollar | superseded | [clm_F54E81BBFB95](/claim/clm_F54E81BBFB95.md) - 2020-05-01 to 2020-07-17 | money | shares_outstanding | 697,511,185 shares | superseded | [clm_823A1C3F274B](/claim/clm_823A1C3F274B.md) - 2020-07-03 to 2020-10-02 | money | cash_and_equivalents | 5,539,300,000 United States dollar | superseded | [clm_8A7741643436](/claim/clm_8A7741643436.md) - 2020-07-03 to 2020-10-02 | money | quarterly_net_income | 927,300,000 United States dollar | superseded | [clm_0D2844878159](/claim/clm_0D2844878159.md) - 2020-07-03 to 2020-10-02 | money | quarterly_operating_income | 844,600,000 United States dollar | superseded | [clm_17E97B87D634](/claim/clm_17E97B87D634.md) - 2020-07-03 to 2020-10-02 | money | quarterly_research_and_development | 322,600,000 United States dollar | superseded | [clm_0936C4D4216C](/claim/clm_0936C4D4216C.md) - 2020-07-03 to 2020-10-02 | money | quarterly_revenue | 5,297,400,000 United States dollar | superseded | [clm_3280F0CEDE1D](/claim/clm_3280F0CEDE1D.md) - 2020-07-03 to 2020-10-02 | money | total_assets | 71,268,400,000 United States dollar | superseded | [clm_50A1CF84FC18](/claim/clm_50A1CF84FC18.md) - 2020-07-03 to 2020-10-02 | money | total_equity | 36,261,700,000 United States dollar | superseded | [clm_B5292857E533](/claim/clm_B5292857E533.md) - 2020-07-17 to 2020-10-16 | money | shares_outstanding | 709,408,837 shares | superseded | [clm_33898372B9A5](/claim/clm_33898372B9A5.md) - 2020-10-02 | money | cash_and_equivalents | 5,687,700,000 United States dollar | valid | [clm_53E1762D9768](/claim/clm_53E1762D9768.md) - 2020-10-02 to 2021-04-02 | money | quarterly_net_income | 883,500,000 United States dollar | superseded | [clm_A38E78000381](/claim/clm_A38E78000381.md) - 2020-10-02 to 2021-04-02 | money | quarterly_operating_income | 1,087,600,000 United States dollar | superseded | [clm_6D0BEBDE2F45](/claim/clm_6D0BEBDE2F45.md) - 2020-10-02 to 2021-04-02 | money | quarterly_research_and_development | 342,600,000 United States dollar | superseded | [clm_30748EEB2E60](/claim/clm_30748EEB2E60.md) - 2020-10-02 to 2021-04-02 | money | quarterly_revenue | 5,883,200,000 United States dollar | superseded | [clm_6395F98217EA](/claim/clm_6395F98217EA.md) - 2020-10-02 to 2020-12-31 | money | total_assets | 72,890,700,000 United States dollar | superseded | [clm_3FB7FDDDF711](/claim/clm_3FB7FDDDF711.md) - 2020-10-02 to 2020-12-31 | money | total_equity | 37,961,000,000 United States dollar | superseded | [clm_FDFA9435803E](/claim/clm_FDFA9435803E.md) - 2020-10-16 to 2021-02-05 | money | shares_outstanding | 710,377,467 shares | superseded | [clm_C1D97787947C](/claim/clm_C1D97787947C.md) - 2020-12-31 to 2021-12-31 | money | net_income | 3,646,000,000 United States dollar | superseded | [clm_4B0D8E46AFA6](/claim/clm_4B0D8E46AFA6.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 4,231,000,000 United States dollar | superseded | [clm_D05C4BE3CFA0](/claim/clm_D05C4BE3CFA0.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 1,348,000,000 United States dollar | superseded | [clm_4C80A2C52666](/claim/clm_4C80A2C52666.md) - 2020-12-31 to 2021-12-31 | money | revenue | 22,284,000,000 United States dollar | superseded | [clm_91096D239E82](/claim/clm_91096D239E82.md) - 2020-12-31 to 2021-04-02 | money | total_assets | 76,161,000,000 United States dollar | superseded | [clm_2AA58363A9EA](/claim/clm_2AA58363A9EA.md) - 2020-12-31 to 2021-04-02 | money | total_equity | 39,766,000,000 United States dollar | superseded | [clm_44C3D2FA3A85](/claim/clm_44C3D2FA3A85.md) ## 2021 - 2021-02-05 to 2021-04-16 | money | shares_outstanding | 712,204,198 shares | superseded | [clm_BFD68EE1575D](/claim/clm_BFD68EE1575D.md) - 2021-04-02 to 2021-07-02 | money | quarterly_net_income | 1,702,000,000 United States dollar | superseded | [clm_48D8D57ECB21](/claim/clm_48D8D57ECB21.md) - 2021-04-02 to 2021-07-02 | money | quarterly_operating_income | 1,997,000,000 United States dollar | superseded | [clm_8D120EAE7C57](/claim/clm_8D120EAE7C57.md) - 2021-04-02 to 2021-07-02 | money | quarterly_research_and_development | 380,000,000 United States dollar | superseded | [clm_1874916E998C](/claim/clm_1874916E998C.md) - 2021-04-02 to 2021-07-02 | money | quarterly_revenue | 6,858,000,000 United States dollar | superseded | [clm_A852F4CCF081](/claim/clm_A852F4CCF081.md) - 2021-04-02 to 2021-07-02 | money | total_assets | 75,426,000,000 United States dollar | superseded | [clm_4DF7D0357075](/claim/clm_4DF7D0357075.md) - 2021-04-02 to 2021-07-02 | money | total_equity | 40,419,000,000 United States dollar | superseded | [clm_EB30D9332EE3](/claim/clm_EB30D9332EE3.md) - 2021-04-16 to 2021-07-16 | money | shares_outstanding | 713,278,866 shares | superseded | [clm_F9F9B46E6AE7](/claim/clm_F9F9B46E6AE7.md) - 2021-07-02 to 2021-10-01 | money | quarterly_net_income | 1,785,000,000 United States dollar | superseded | [clm_947285C029C1](/claim/clm_947285C029C1.md) - 2021-07-02 to 2021-10-01 | money | quarterly_operating_income | 2,005,000,000 United States dollar | superseded | [clm_81E012CE1523](/claim/clm_81E012CE1523.md) - 2021-07-02 to 2021-10-01 | money | quarterly_research_and_development | 426,000,000 United States dollar | superseded | [clm_32814E6892F9](/claim/clm_32814E6892F9.md) - 2021-07-02 to 2021-10-01 | money | quarterly_revenue | 7,218,000,000 United States dollar | superseded | [clm_DC8026697E56](/claim/clm_DC8026697E56.md) - 2021-07-02 to 2021-10-01 | money | total_assets | 78,027,000,000 United States dollar | superseded | [clm_3160B329679A](/claim/clm_3160B329679A.md) - 2021-07-02 to 2021-10-01 | money | total_equity | 42,756,000,000 United States dollar | superseded | [clm_E2567B62B85B](/claim/clm_E2567B62B85B.md) - 2021-07-16 to 2021-10-15 | money | shares_outstanding | 713,899,565 shares | superseded | [clm_6273C24F60CE](/claim/clm_6273C24F60CE.md) - 2021-10-01 to 2022-04-01 | money | quarterly_net_income | 1,158,000,000 United States dollar | superseded | [clm_D6916A3B2BC0](/claim/clm_D6916A3B2BC0.md) - 2021-10-01 to 2022-04-01 | money | quarterly_operating_income | 1,309,000,000 United States dollar | superseded | [clm_981A98624F16](/claim/clm_981A98624F16.md) - 2021-10-01 to 2022-04-01 | money | quarterly_research_and_development | 441,000,000 United States dollar | superseded | [clm_3D55BAF23D13](/claim/clm_3D55BAF23D13.md) - 2021-10-01 to 2022-04-01 | money | quarterly_revenue | 7,229,000,000 United States dollar | superseded | [clm_8035DF965225](/claim/clm_8035DF965225.md) - 2021-10-01 to 2021-12-31 | money | total_assets | 82,498,000,000 United States dollar | superseded | [clm_51F31165E8D0](/claim/clm_51F31165E8D0.md) - 2021-10-01 to 2021-12-31 | money | total_equity | 43,451,000,000 United States dollar | superseded | [clm_C02977F5CBC9](/claim/clm_C02977F5CBC9.md) - 2021-10-15 to 2022-02-04 | money | shares_outstanding | 714,576,868 shares | superseded | [clm_FF479EEFE02D](/claim/clm_FF479EEFE02D.md) - 2021-12-31 to 2022-12-31 | money | net_income | 6,433,000,000 United States dollar | superseded | [clm_EF0DB8CB8472](/claim/clm_EF0DB8CB8472.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 7,465,000,000 United States dollar | superseded | [clm_B5EC4A8B1811](/claim/clm_B5EC4A8B1811.md) - 2021-12-31 to 2022-12-31 | money | research_and_development | 1,742,000,000 United States dollar | superseded | [clm_5DCC4AB6A1E7](/claim/clm_5DCC4AB6A1E7.md) - 2021-12-31 to 2022-12-31 | money | revenue | 29,453,000,000 United States dollar | superseded | [clm_75DF9F80B995](/claim/clm_75DF9F80B995.md) - 2021-12-31 to 2022-04-01 | money | total_assets | 83,184,000,000 United States dollar | superseded | [clm_7F7A6CDFEAE4](/claim/clm_7F7A6CDFEAE4.md) - 2021-12-31 to 2022-04-01 | money | total_equity | 45,167,000,000 United States dollar | superseded | [clm_9D17584192BC](/claim/clm_9D17584192BC.md) ## 2022 - 2022-02-04 to 2022-04-19 | money | shares_outstanding | 715,352,586 shares | superseded | [clm_B0735E4CDB59](/claim/clm_B0735E4CDB59.md) - 2022-04-01 to 2022-07-01 | money | quarterly_net_income | 1,725,000,000 United States dollar | superseded | [clm_5048D06B2E5B](/claim/clm_5048D06B2E5B.md) - 2022-04-01 to 2022-07-01 | money | quarterly_operating_income | 2,172,000,000 United States dollar | superseded | [clm_9E9E90CC511B](/claim/clm_9E9E90CC511B.md) - 2022-04-01 to 2022-07-01 | money | quarterly_research_and_development | 441,000,000 United States dollar | superseded | [clm_9597F57F11D0](/claim/clm_9597F57F11D0.md) - 2022-04-01 to 2022-07-01 | money | quarterly_revenue | 7,688,000,000 United States dollar | superseded | [clm_12F6878AC69D](/claim/clm_12F6878AC69D.md) - 2022-04-01 to 2022-07-01 | money | total_assets | 83,392,000,000 United States dollar | superseded | [clm_29EDC1F8B0C3](/claim/clm_29EDC1F8B0C3.md) - 2022-04-01 to 2022-07-01 | money | total_equity | 46,356,000,000 United States dollar | superseded | [clm_7DE3C55841C3](/claim/clm_7DE3C55841C3.md) - 2022-04-19 to 2022-07-15 | money | shares_outstanding | 727,076,766 shares | superseded | [clm_851C5B68B827](/claim/clm_851C5B68B827.md) - 2022-07-01 to 2022-09-30 | money | quarterly_net_income | 1,680,000,000 United States dollar | superseded | [clm_0E9B7A1A5B92](/claim/clm_0E9B7A1A5B92.md) - 2022-07-01 to 2022-09-30 | money | quarterly_operating_income | 2,205,000,000 United States dollar | superseded | [clm_4A39D6B10C79](/claim/clm_4A39D6B10C79.md) - 2022-07-01 to 2022-09-30 | money | quarterly_research_and_development | 431,000,000 United States dollar | superseded | [clm_3232A9B9B00A](/claim/clm_3232A9B9B00A.md) - 2022-07-01 to 2022-09-30 | money | quarterly_revenue | 7,751,000,000 United States dollar | superseded | [clm_B05487B12F91](/claim/clm_B05487B12F91.md) - 2022-07-01 to 2022-09-30 | money | total_assets | 81,806,000,000 United States dollar | superseded | [clm_805D30BDC50E](/claim/clm_805D30BDC50E.md) - 2022-07-01 to 2022-09-30 | money | total_equity | 46,594,000,000 United States dollar | superseded | [clm_05CF9CEB1B10](/claim/clm_05CF9CEB1B10.md) - 2022-07-15 to 2022-10-14 | money | shares_outstanding | 727,445,355 shares | superseded | [clm_AC1E0CD0D6CC](/claim/clm_AC1E0CD0D6CC.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 1,572,000,000 United States dollar | superseded | [clm_0F9D84048D0E](/claim/clm_0F9D84048D0E.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 2,015,000,000 United States dollar | superseded | [clm_0647F4E41394](/claim/clm_0647F4E41394.md) - 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 420,000,000 United States dollar | superseded | [clm_178C3698BC08](/claim/clm_178C3698BC08.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 7,663,000,000 United States dollar | superseded | [clm_F9ED7BF561C3](/claim/clm_F9ED7BF561C3.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 81,030,000,000 United States dollar | superseded | [clm_80D815BB9502](/claim/clm_80D815BB9502.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 46,985,000,000 United States dollar | superseded | [clm_2A1295F3A5DA](/claim/clm_2A1295F3A5DA.md) - 2022-10-14 to 2023-02-03 | money | shares_outstanding | 727,962,702 shares | superseded | [clm_B32FD3DECD08](/claim/clm_B32FD3DECD08.md) - 2022-12-31 to 2023-12-31 | money | net_income | 7,209,000,000 United States dollar | superseded | [clm_6DA0B1D3BCE8](/claim/clm_6DA0B1D3BCE8.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 8,688,000,000 United States dollar | superseded | [clm_1CC8B1A7A1D5](/claim/clm_1CC8B1A7A1D5.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 1,745,000,000 United States dollar | superseded | [clm_840338266982](/claim/clm_840338266982.md) - 2022-12-31 to 2023-12-31 | money | revenue | 31,471,000,000 United States dollar | superseded | [clm_DCFF76269B5D](/claim/clm_DCFF76269B5D.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 84,350,000,000 United States dollar | superseded | [clm_4CFB40072C21](/claim/clm_4CFB40072C21.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 50,082,000,000 United States dollar | superseded | [clm_CE17804E22CD](/claim/clm_CE17804E22CD.md) ## 2023 - 2023-02-03 to 2023-04-20 | money | shares_outstanding | 728,576,886 shares | superseded | [clm_B06F47665304](/claim/clm_B06F47665304.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 1,450,000,000 United States dollar | superseded | [clm_DE4CEE7ED281](/claim/clm_DE4CEE7ED281.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 1,794,000,000 United States dollar | superseded | [clm_48B70A158DE0](/claim/clm_48B70A158DE0.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 429,000,000 United States dollar | superseded | [clm_AB722FC1EA8B](/claim/clm_AB722FC1EA8B.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 7,167,000,000 United States dollar | superseded | [clm_FB093AD6F3D2](/claim/clm_FB093AD6F3D2.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 85,040,000,000 United States dollar | superseded | [clm_85F1D09E753C](/claim/clm_85F1D09E753C.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 51,478,000,000 United States dollar | superseded | [clm_E85A2FCB539D](/claim/clm_E85A2FCB539D.md) - 2023-04-20 to 2023-07-20 | money | shares_outstanding | 737,898,789 shares | superseded | [clm_0336166904AF](/claim/clm_0336166904AF.md) - 2023-06-30 to 2023-09-29 | money | quarterly_net_income | 1,106,000,000 United States dollar | superseded | [clm_BB0AB9C3BA5F](/claim/clm_BB0AB9C3BA5F.md) - 2023-06-30 to 2023-09-29 | money | quarterly_operating_income | 1,429,000,000 United States dollar | superseded | [clm_236B0016C07E](/claim/clm_236B0016C07E.md) - 2023-06-30 to 2023-09-29 | money | quarterly_research_and_development | 418,000,000 United States dollar | superseded | [clm_DA0F380F939B](/claim/clm_DA0F380F939B.md) - 2023-06-30 to 2023-09-29 | money | quarterly_revenue | 7,157,000,000 United States dollar | superseded | [clm_4987F235B06E](/claim/clm_4987F235B06E.md) - 2023-06-30 to 2023-09-29 | money | total_assets | 84,902,000,000 United States dollar | superseded | [clm_59ABEB879A63](/claim/clm_59ABEB879A63.md) - 2023-06-30 to 2023-09-29 | money | total_equity | 51,716,000,000 United States dollar | superseded | [clm_3469CBAECEFC](/claim/clm_3469CBAECEFC.md) - 2023-07-20 to 2023-10-19 | money | shares_outstanding | 738,352,114 shares | superseded | [clm_32AA7D3A3E98](/claim/clm_32AA7D3A3E98.md) - 2023-09-29 to 2024-03-29 | money | quarterly_net_income | 1,129,000,000 United States dollar | superseded | [clm_C1DF3FEE0F7C](/claim/clm_C1DF3FEE0F7C.md) - 2023-09-29 to 2024-03-29 | money | quarterly_operating_income | 1,438,000,000 United States dollar | superseded | [clm_72C5F24A0F65](/claim/clm_72C5F24A0F65.md) - 2023-09-29 to 2024-03-29 | money | quarterly_research_and_development | 417,000,000 United States dollar | superseded | [clm_F0162707BB56](/claim/clm_F0162707BB56.md) - 2023-09-29 to 2024-03-29 | money | quarterly_revenue | 6,873,000,000 United States dollar | superseded | [clm_C4B6C96B19B3](/claim/clm_C4B6C96B19B3.md) - 2023-09-29 to 2023-12-31 | money | total_assets | 87,734,000,000 United States dollar | superseded | [clm_A3B3F040EAFA](/claim/clm_A3B3F040EAFA.md) - 2023-09-29 to 2023-12-31 | money | total_equity | 52,407,000,000 United States dollar | superseded | [clm_52701D5BBD79](/claim/clm_52701D5BBD79.md) - 2023-10-19 to 2024-02-02 | money | shares_outstanding | 738,927,107 shares | superseded | [clm_BA6A4CD7A29D](/claim/clm_BA6A4CD7A29D.md) - 2023-12-31 to 2024-12-31 | money | net_income | 4,764,000,000 United States dollar | superseded | [clm_F30B1725842C](/claim/clm_F30B1725842C.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 5,202,000,000 United States dollar | superseded | [clm_2AC0CE01AA00](/claim/clm_2AC0CE01AA00.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 1,503,000,000 United States dollar | superseded | [clm_DA980660821B](/claim/clm_DA980660821B.md) - 2023-12-31 to 2024-12-31 | money | revenue | 23,890,000,000 United States dollar | superseded | [clm_09ECD54DDF84](/claim/clm_09ECD54DDF84.md) - 2023-12-31 to 2024-03-29 | money | total_assets | 84,488,000,000 United States dollar | superseded | [clm_8973C4F6F9BE](/claim/clm_8973C4F6F9BE.md) - 2023-12-31 to 2024-03-29 | money | total_equity | 53,486,000,000 United States dollar | superseded | [clm_283114FF0932](/claim/clm_283114FF0932.md) ## 2024 - 2024-02-02 to 2024-04-18 | money | shares_outstanding | 739,701,725 shares | superseded | [clm_9E4BAECAA0D6](/claim/clm_9E4BAECAA0D6.md) - 2024-03-29 to 2024-06-28 | money | quarterly_net_income | 1,088,000,000 United States dollar | superseded | [clm_41D09B1AFCA8](/claim/clm_41D09B1AFCA8.md) - 2024-03-29 to 2024-06-28 | money | quarterly_operating_income | 1,312,000,000 United States dollar | superseded | [clm_18E5AB78B2C9](/claim/clm_18E5AB78B2C9.md) - 2024-03-29 to 2024-06-28 | money | quarterly_research_and_development | 368,000,000 United States dollar | superseded | [clm_401B664F4EB1](/claim/clm_401B664F4EB1.md) - 2024-03-29 to 2024-06-28 | money | quarterly_revenue | 5,796,000,000 United States dollar | superseded | [clm_52C551808252](/claim/clm_52C551808252.md) - 2024-03-29 to 2024-06-28 | money | total_assets | 83,402,000,000 United States dollar | superseded | [clm_A2197D64E9D9](/claim/clm_A2197D64E9D9.md) - 2024-03-29 to 2024-06-28 | money | total_equity | 53,442,000,000 United States dollar | superseded | [clm_82D523118E9D](/claim/clm_82D523118E9D.md) - 2024-04-18 to 2024-07-18 | money | shares_outstanding | 740,686,541 shares | superseded | [clm_2F2A5E9318F2](/claim/clm_2F2A5E9318F2.md) - 2024-06-28 to 2024-09-27 | money | quarterly_net_income | 907,000,000 United States dollar | superseded | [clm_314BEF55A223](/claim/clm_314BEF55A223.md) - 2024-06-28 to 2024-09-27 | money | quarterly_operating_income | 1,168,000,000 United States dollar | superseded | [clm_804324483834](/claim/clm_804324483834.md) - 2024-06-28 to 2024-09-27 | money | quarterly_research_and_development | 391,000,000 United States dollar | superseded | [clm_BD8614582E1E](/claim/clm_BD8614582E1E.md) - 2024-06-28 to 2024-09-27 | money | quarterly_revenue | 5,743,000,000 United States dollar | superseded | [clm_FBC749C2E367](/claim/clm_FBC749C2E367.md) - 2024-06-28 to 2024-09-27 | money | total_assets | 78,555,000,000 United States dollar | superseded | [clm_166CDFDEB257](/claim/clm_166CDFDEB257.md) - 2024-06-28 to 2024-09-27 | money | total_equity | 49,897,000,000 United States dollar | superseded | [clm_A159395E2F1C](/claim/clm_A159395E2F1C.md) - 2024-07-18 to 2024-10-17 | money | shares_outstanding | 722,213,081 shares | superseded | [clm_6796E874BB19](/claim/clm_6796E874BB19.md) - 2024-09-27 to 2025-03-28 | money | quarterly_net_income | 818,000,000 United States dollar | superseded | [clm_C324D14416AD](/claim/clm_C324D14416AD.md) - 2024-09-27 to 2025-03-28 | money | quarterly_operating_income | 958,000,000 United States dollar | superseded | [clm_7D434594FEA3](/claim/clm_7D434594FEA3.md) - 2024-09-27 to 2025-03-28 | money | quarterly_research_and_development | 383,000,000 United States dollar | superseded | [clm_136F8FA9E00E](/claim/clm_136F8FA9E00E.md) - 2024-09-27 to 2025-03-28 | money | quarterly_revenue | 5,798,000,000 United States dollar | superseded | [clm_77D5A120E632](/claim/clm_77D5A120E632.md) - 2024-09-27 to 2024-12-31 | money | total_assets | 80,615,000,000 United States dollar | superseded | [clm_FF60254DC364](/claim/clm_FF60254DC364.md) - 2024-09-27 to 2024-12-31 | money | total_equity | 51,299,000,000 United States dollar | superseded | [clm_C8700C15351F](/claim/clm_C8700C15351F.md) - 2024-10-17 to 2025-02-03 | money | shares_outstanding | 722,275,141 shares | superseded | [clm_C2D1FC46A5D1](/claim/clm_C2D1FC46A5D1.md) - 2024-12-31 to 2025-12-31 | money | net_income | 3,899,000,000 United States dollar | superseded | [clm_4C917CF2906D](/claim/clm_4C917CF2906D.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 4,863,000,000 United States dollar | superseded | [clm_95DE20676AE9](/claim/clm_95DE20676AE9.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 1,584,000,000 United States dollar | superseded | [clm_10ED9E5C3F97](/claim/clm_10ED9E5C3F97.md) - 2024-12-31 to 2025-12-31 | money | revenue | 23,875,000,000 United States dollar | superseded | [clm_7C2DC4B868C8](/claim/clm_7C2DC4B868C8.md) - 2024-12-31 to 2025-03-28 | money | total_assets | 77,542,000,000 United States dollar | superseded | [clm_5BFF6AC3591F](/claim/clm_5BFF6AC3591F.md) - 2024-12-31 to 2025-03-28 | money | total_equity | 49,543,000,000 United States dollar | superseded | [clm_95AF9E4EDEC4](/claim/clm_95AF9E4EDEC4.md) ## 2025 - 2025-02-03 to 2025-04-16 | money | shares_outstanding | 714,709,852 shares | superseded | [clm_C076056C4522](/claim/clm_C076056C4522.md) - 2025-03-28 to 2025-06-27 | money | quarterly_net_income | 954,000,000 United States dollar | superseded | [clm_87ADFFE75F02](/claim/clm_87ADFFE75F02.md) - 2025-03-28 to 2025-06-27 | money | quarterly_operating_income | 1,274,000,000 United States dollar | superseded | [clm_F8A675105B85](/claim/clm_F8A675105B85.md) - 2025-03-28 to 2025-06-27 | money | quarterly_research_and_development | 379,000,000 United States dollar | superseded | [clm_1F64DF7BEF37](/claim/clm_1F64DF7BEF37.md) - 2025-03-28 to 2025-06-27 | money | quarterly_revenue | 5,741,000,000 United States dollar | superseded | [clm_37F4BAC3EF24](/claim/clm_37F4BAC3EF24.md) - 2025-03-28 to 2025-06-27 | money | total_assets | 79,116,000,000 United States dollar | superseded | [clm_2061C387A911](/claim/clm_2061C387A911.md) - 2025-03-28 to 2025-06-27 | money | total_equity | 50,849,000,000 United States dollar | superseded | [clm_416753AE76AC](/claim/clm_416753AE76AC.md) - 2025-04-16 to 2025-07-17 | money | shares_outstanding | 715,669,594 shares | superseded | [clm_6A27C7A9DFBA](/claim/clm_6A27C7A9DFBA.md) - 2025-06-27 to 2025-09-26 | money | quarterly_net_income | 555,000,000 United States dollar | superseded | [clm_4ED2C435880A](/claim/clm_4ED2C435880A.md) - 2025-06-27 to 2025-09-26 | money | quarterly_operating_income | 760,000,000 United States dollar | superseded | [clm_106E38D665E9](/claim/clm_106E38D665E9.md) - 2025-06-27 to 2025-09-26 | money | quarterly_research_and_development | 403,000,000 United States dollar | superseded | [clm_F1AB30B267CE](/claim/clm_F1AB30B267CE.md) - 2025-06-27 to 2025-09-26 | money | quarterly_revenue | 5,936,000,000 United States dollar | superseded | [clm_2385C03D63F3](/claim/clm_2385C03D63F3.md) - 2025-06-27 to 2025-09-26 | money | total_assets | 81,620,000,000 United States dollar | superseded | [clm_D59DE5B48251](/claim/clm_D59DE5B48251.md) - 2025-06-27 to 2025-09-26 | money | total_equity | 52,334,000,000 United States dollar | superseded | [clm_3C96937A704F](/claim/clm_3C96937A704F.md) - 2025-07-17 to 2025-10-16 | money | shares_outstanding | 716,051,590 shares | superseded | [clm_C7CD4EB7E97B](/claim/clm_C7CD4EB7E97B.md) - 2025-09-26 to 2026-03-27 | money | quarterly_net_income | 908,000,000 United States dollar | superseded | [clm_88AAE15C5716](/claim/clm_88AAE15C5716.md) - 2025-09-26 to 2026-03-27 | money | quarterly_operating_income | 1,154,000,000 United States dollar | superseded | [clm_0696B89A6FC1](/claim/clm_0696B89A6FC1.md) - 2025-09-26 to 2026-03-27 | money | quarterly_research_and_development | 378,000,000 United States dollar | superseded | [clm_AB9C34F519DA](/claim/clm_AB9C34F519DA.md) - 2025-09-26 to 2026-03-27 | money | quarterly_revenue | 6,053,000,000 United States dollar | superseded | [clm_D22DAD6BEA7F](/claim/clm_D22DAD6BEA7F.md) - 2025-09-26 to 2025-12-31 | money | total_assets | 79,897,000,000 United States dollar | superseded | [clm_00DC4A86A945](/claim/clm_00DC4A86A945.md) - 2025-09-26 to 2025-12-31 | money | total_equity | 51,071,000,000 United States dollar | superseded | [clm_CCF0316F1770](/claim/clm_CCF0316F1770.md) - 2025-10-16 to 2026-02-02 | money | shares_outstanding | 706,349,563 shares | superseded | [clm_0FB3AA89EA1D](/claim/clm_0FB3AA89EA1D.md) - 2025-12-31 | money | net_income | 3,614,000,000 United States dollar | valid | [clm_FDDA7DEA3471](/claim/clm_FDDA7DEA3471.md) - 2025-12-31 | money | operating_income | 4,690,000,000 United States dollar | valid | [clm_5D42E1C875CA](/claim/clm_5D42E1C875CA.md) - 2025-12-31 | money | research_and_development | 1,598,000,000 United States dollar | valid | [clm_5307ED9498D1](/claim/clm_5307ED9498D1.md) - 2025-12-31 | money | revenue | 24,568,000,000 United States dollar | valid | [clm_7D46877ADB1B](/claim/clm_7D46877ADB1B.md) - 2025-12-31 to 2026-03-27 | money | total_assets | 83,464,000,000 United States dollar | superseded | [clm_312ED642DFD5](/claim/clm_312ED642DFD5.md) - 2025-12-31 to 2026-03-27 | money | total_equity | 52,534,000,000 United States dollar | superseded | [clm_80C4996709D8](/claim/clm_80C4996709D8.md) ## 2026 - 2026-02-02 to 2026-04-16 | money | shares_outstanding | 707,139,356 shares | superseded | [clm_A8A94C52765F](/claim/clm_A8A94C52765F.md) - 2026-03-27 to 2026-06-26 | money | quarterly_net_income | 1,029,000,000 United States dollar | superseded | [clm_B65E3DF0F87C](/claim/clm_B65E3DF0F87C.md) - 2026-03-27 to 2026-06-26 | money | quarterly_operating_income | 1,344,000,000 United States dollar | superseded | [clm_CB486711DB10](/claim/clm_CB486711DB10.md) - 2026-03-27 to 2026-06-26 | money | quarterly_research_and_development | 387,000,000 United States dollar | superseded | [clm_E9BA3264E883](/claim/clm_E9BA3264E883.md) - 2026-03-27 to 2026-06-26 | money | quarterly_revenue | 5,951,000,000 United States dollar | superseded | [clm_391E715615E7](/claim/clm_391E715615E7.md) - 2026-03-27 to 2026-06-26 | money | total_assets | 83,544,000,000 United States dollar | superseded | [clm_F41915C9C6D3](/claim/clm_F41915C9C6D3.md) - 2026-03-27 to 2026-06-26 | money | total_equity | 52,949,000,000 United States dollar | superseded | [clm_1B02B5BCDF94](/claim/clm_1B02B5BCDF94.md) - 2026-04-16 to 2026-07-16 | money | shares_outstanding | 707,770,627 shares | superseded | [clm_FDEDAAAE8C7B](/claim/clm_FDEDAAAE8C7B.md) - 2026-06-26 to 2026-09-25 | money | quarterly_net_income | 870,000,000 United States dollar | superseded | [clm_20D970B209BA](/claim/clm_20D970B209BA.md) - 2026-06-26 to 2026-09-25 | money | quarterly_operating_income | 1,127,000,000 United States dollar | superseded | [clm_C156511111B4](/claim/clm_C156511111B4.md) - 2026-06-26 to 2026-09-25 | money | quarterly_research_and_development | 412,000,000 United States dollar | superseded | [clm_3410661D1369](/claim/clm_3410661D1369.md) - 2026-06-26 to 2026-09-25 | money | quarterly_revenue | 6,265,000,000 United States dollar | superseded | [clm_7BDBC2FB9AEC](/claim/clm_7BDBC2FB9AEC.md) - 2026-06-26 to 2026-09-25 | money | total_assets | 92,367,000,000 United States dollar | superseded | [clm_A36A77E6723A](/claim/clm_A36A77E6723A.md) - 2026-06-26 to 2026-09-25 | money | total_equity | 52,581,000,000 United States dollar | superseded | [clm_3C0D2703E0BA](/claim/clm_3C0D2703E0BA.md) - 2026-07-16 to 2026-10-15 | money | shares_outstanding | 702,986,054 shares | superseded | [clm_2146249DFF48](/claim/clm_2146249DFF48.md) - 2026-09-25 | money | quarterly_net_income | 1,235,000,000 United States dollar | valid | [clm_EC024560AF10](/claim/clm_EC024560AF10.md) - 2026-09-25 | money | quarterly_operating_income | 1,245,000,000 United States dollar | valid | [clm_6D8E0B99E86E](/claim/clm_6D8E0B99E86E.md) - 2026-09-25 | money | quarterly_research_and_development | 433,000,000 United States dollar | valid | [clm_7389622D0286](/claim/clm_7389622D0286.md) - 2026-09-25 | money | quarterly_revenue | 6,554,000,000 United States dollar | valid | [clm_6A3284838BFB](/claim/clm_6A3284838BFB.md) - 2026-09-25 | money | total_assets | 93,281,000,000 United States dollar | valid | [clm_888F4DF076B1](/claim/clm_888F4DF076B1.md) - 2026-09-25 | money | total_equity | 53,621,000,000 United States dollar | valid | [clm_012474B8D465](/claim/clm_012474B8D465.md) - 2026-10-01 | people | ceo | Julie Sawyer Montgomery | valid | [clm_A56ECE7EF5B8](/claim/clm_A56ECE7EF5B8.md) - 2026-10-15 | money | shares_outstanding | 703,530,815 shares | valid | [clm_6D2BB1A842FD](/claim/clm_6D2BB1A842FD.md) ## undated - undated | other | cik | 0000313616 | valid | [clm_3F5E0F0F78B3](/claim/clm_3F5E0F0F78B3.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_9FAD6554240B](/claim/clm_9FAD6554240B.md) - undated | other | headquarters | Washington | valid | [clm_BDA256A23DC8](/claim/clm_BDA256A23DC8.md) - undated | other | listed_on | NYSE | valid | [clm_C895D6358FA2](/claim/clm_C895D6358FA2.md) - undated | other | registrant_name | DANAHER CORP /DE/ | valid | [clm_71B83A2AABBA](/claim/clm_71B83A2AABBA.md) - undated | other | sic_industry | Industrial Instruments For Measurement, Display, and Control (3823) | valid | [clm_2BD0B7CABEB8](/claim/clm_2BD0B7CABEB8.md) - undated | other | state_of_incorporation | DE | valid | [clm_25AED09F491C](/claim/clm_25AED09F491C.md) - undated | other | ticker | DHR | valid | [clm_9336C471E6D5](/claim/clm_9336C471E6D5.md) - undated | other | website | https://www.danaher.com/ | unverified | [clm_15B6C7E0FF96](/claim/clm_15B6C7E0FF96.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.